MS
MCID: MLT020
MIFTS: 72

Multiple Sclerosis (MS)

Categories: Genetic diseases, Immune diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Multiple Sclerosis

MalaCards integrated aliases for Multiple Sclerosis:

Name: Multiple Sclerosis 56 12 74 52 25 53 73 36 54 6 42 43 15 37 17 71 32
Ms 56 52 25 73
Multiple Sclerosis, Disease Progression, Modifier of 56 13
Multiple Sclerosis Modifier of Disease Progression 29 6
Disseminated Sclerosis 56 25
Multiple Sclerosis, Susceptibility to, 1 56
Multiple Sclerosis, Susceptibility to 56
Multiple Sclerosis Susceptibility to 39
Generalized Multiple Sclerosis 12
Multiple Sclerosis Variant 58
Multiple Sclerosis 1 56
Insular Sclerosis 12

Characteristics:

OMIM:

56
Inheritance:
multifactorial

Miscellaneous:
onset 20-55 years of age
women affected more than men (3:2)
association with the hla-drb1*1501-dqb1*0602 haplotype has been repeatedly demonstrated in high-risk (northern european) populations.


HPO:

31
multiple sclerosis:
Inheritance multifactorial inheritance


Classifications:

Orphanet: 58  
Rare neurological diseases


External Ids:

Disease Ontology 12 DOID:2377
OMIM 56 126200
OMIM Phenotypic Series 56 PS126200
KEGG 36 H01490
ICD9CM 34 340
NCIt 49 C3243
SNOMED-CT 67 24700007
ICD10 32 G35
Orphanet 58 ORPHA228145
MedGen 41 C1868685
UMLS 71 C0026769

Summaries for Multiple Sclerosis

Genetics Home Reference : 25 Multiple sclerosis is a condition characterized by areas of damage (lesions) on the brain and spinal cord. These lesions are associated with destruction of the covering that protects nerves and promotes the efficient transmission of nerve impulses (the myelin sheath) and damage to nerve cells. Multiple sclerosis is considered an autoimmune disorder; autoimmune disorders occur when the immune system malfunctions and attacks the body's own tissues and organs, in this case tissues of the nervous system. Multiple sclerosis usually begins in early adulthood, between ages 20 and 40. The symptoms vary widely, and affected individuals can experience one or more effects of nervous system damage. Multiple sclerosis often causes sensory disturbances in the limbs, including a prickling or tingling sensation (paresthesia), numbness, pain, and itching. Some people experience Lhermitte sign, which is an electrical shock-like sensation that runs down the back and into the limbs. This sensation usually occurs when the head is bent forward. Problems with muscle control are common in people with multiple sclerosis. Affected individuals may have tremors, muscle stiffness (spasticity), exaggerated reflexes (hyperreflexia), weakness or partial paralysis of the muscles of the limbs, difficulty walking, or poor bladder control. Multiple sclerosis is also associated with vision problems, such as blurred or double vision or partial or complete vision loss. Infections that cause fever can make the symptoms worse. There are several forms of multiple sclerosis: relapsing-remitting MS, secondary progressive MS, primary progressive MS, and progressive relapsing MS. The most common is the relapsing-remitting form, which affects approximately 80 percent of people with multiple sclerosis. Individuals with this form of the condition have periods during which they experience symptoms, called clinical attacks, followed by periods without any symptoms (remission). The triggers of clinical attacks and remissions are unknown. After about 10 years, relapsing-remitting MS usually develops into another form of the disorder called secondary progressive MS. In this form, there are no remissions, and symptoms of the condition continually worsen. Primary progressive MS is the next most common form, affecting approximately 10 to 20 percent of people with multiple sclerosis. This form is characterized by constant symptoms that worsen over time, with no clinical attacks or remissions. Primary progressive MS typically begins later than the other forms, around age 40. Progressive relapsing MS is a rare form of multiple sclerosis that initially appears like primary progressive MS, with constant symptoms. However, people with progressive relapsing MS also experience clinical attacks of more severe symptoms.

MalaCards based summary : Multiple Sclerosis, also known as ms, is related to pediatric multiple sclerosis and hypersomnia, and has symptoms including seizures, tremor and back pain. An important gene associated with Multiple Sclerosis is PDCD1 (Programmed Cell Death 1), and among its related pathways/superpathways are Cell adhesion molecules (CAMs) and MicroRNAs in cancer. The drugs Dinoprostone and Mitoxantrone have been mentioned in the context of this disorder. Affiliated tissues include Neural Tube and Limb, and related phenotypes are muscle weakness and spasticity

Disease Ontology : 12 A demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring.

NIH Rare Diseases : 52 Multiple sclerosis (MS) is a degenerative disorder that affects the central nervous system , specifically the brain and the spinal cord. The disorder is characterized by destruction of the myelin , the fatty tissue that surrounds and protects the nerve fibers and promotes the transmission of nerve impulses, and damage to nerve cells . The symptoms vary widely from person to person, and may include sensory disturbances in the limbs, problems with muscle control, tremors, muscle stiffness (spasticity ), exaggerated reflexes (hyperreflexia), weakness, difficulty walking, poor bladder control, and vision problems. Most patients have periods during which they have symptoms (clinical attacks). The clinical attacks are typically followed by periods without any symptoms (remission ). After several years, the symptoms worsen continuously. Multiple sclerosis is considered an autoimmune disorder but the exact cause is unknown. Risk factors for developing multiple sclerosis include genetic factors like changes in the HLA-DRB1 gene and in the IL7R gene and environmental factors , such as exposure to the Epstein-Barr virus , low levels of vitamin D, and smoking. The goal of treatment of MS is to decrease attacks and the inflammation within the central nervous system.

OMIM : 56 Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system (CNS) with various degrees of axonal damage. MS affects mainly young adults with predominance for females. The disorder often leads to substantial disability (summary by Bomprezzi et al., 2003). (126200)

MedlinePlus : 42 Multiple sclerosis (MS) is a nervous system disease that affects your brain and spinal cord. It damages the myelin sheath, the material that surrounds and protects your nerve cells. This damage slows down or blocks messages between your brain and your body, leading to the symptoms of MS. They can include Visual disturbances Muscle weakness Trouble with coordination and balance Sensations such as numbness, prickling, or "pins and needles" Thinking and memory problems No one knows what causes MS. It may be an autoimmune disease, which happens when your immune system attacks healthy cells in your body by mistake. Multiple sclerosis affects women more than men. It often begins between the ages of 20 and 40. Usually, the disease is mild, but some people lose the ability to write, speak, or walk. There is no specific test for MS. Doctors use a medical history, physical exam, neurological exam, MRI, and other tests to diagnose it. There is no cure for MS, but medicines may slow it down and help control symptoms. Physical and occupational therapy may also help. NIH: National Institute of Neurological Disorders and Stroke

NINDS : 53 An unpredictable disease of the central nervous system, multiple sclerosis (MS) can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted.  Many investigators believe MS to be an autoimmune disease -- one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault. Such assaults may be linked to an unknown environmental trigger, perhaps a virus. Most people experience their first symptoms of MS between the ages of 20 and 40; the initial symptom of MS is often blurred or double vision, red-green color distortion, or even blindness in one eye.  Most MS patients experience muscle weakness in their extremities and difficulty with coordination and balance.  These symptoms may be severe enough to impair walking or even standing. In the worst cases, MS can produce partial or complete paralysis.  Most people with MS also exhibit paresthesias, transitory abnormal sensory feelings such as numbness, prickling, or "pins and needles" sensations.  Some may also experience pain.  Speech impediments, tremors, and dizziness are other frequent complaints. Occasionally, people with MS have hearing loss. Approximately half of all people with MS experience cognitive impairments such as difficulties with concentration, attention, memory, and poor judgment, but such symptoms are usually mild and are frequently overlooked.  Depression is another common feature of MS.

KEGG : 36 Multiple Sclerosis (MS) is a chronic disease of the central nervous system (CNS) characterized by inflammation, demyelination and axonal loss. This disease typically strikes young adults, especially women. There are four types of MS according to their relapsing or progressive pattern that include relapsing-remitting (RRMS), secondary progressive (SPMS), primary progressive (PPMS), and progressive relapsing (PRMS). In most patients, the disease has a relapsing-remitting course during the first years. Within 10 years, approximately 50% of patients progress to SPMS. The aetiology of MS is not well understood, but it is likely multifactorial, combining both genetic and environmental factors. Recently, the literature on the risk factors for MS has grown substantially. They indicate that a combination of a genetic predisposition, exposure to Epstein-Barr virus, cigarette smoking, and reduced sunlight exposure/vitamin D levels is involved. Authorized first-line treatments are considered equally effective, and include interferon beta and glatiramer acetate. They are primarily directed against inflammation, and might fail to adequately control disease activity in some patients. In that case, it has been recommended to switch these patients early to a therapy of higher efficacy. Currently, 13 different drugs with ten different active components are licensed in the European Union (EU) and the United States (US) for the treatment of MS.

UniProtKB/Swiss-Prot : 73 Multiple sclerosis: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease.

Wikipedia : 74 Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the... more...

Related Diseases for Multiple Sclerosis

Diseases in the Multiple Sclerosis family:

Multiple Sclerosis 2 Multiple Sclerosis 3
Multiple Sclerosis 4 Multiple Sclerosis 5
Secondary Progressive Multiple Sclerosis Primary Progressive Multiple Sclerosis

Diseases related to Multiple Sclerosis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 2160, show less)
# Related Disease Score Top Affiliating Genes
1 pediatric multiple sclerosis 35.0 HLA-DRB1 HLA-DQB1
2 hypersomnia 33.5 HLA-DRB1 HLA-DQB1
3 autoimmune hepatitis 31.8 PDCD1 HLA-DRB1 HLA-DQB1
4 hashimoto thyroiditis 31.1 MIR142 IFNG-AS1 HLA-DRB1 HLA-DQB1
5 psoriasis 31.0 MIR326 MIR20A MIR17 MIR142 HLA-DRB1
6 central nervous system disease 31.0 MIR223 MIR17 MIR145 MIR142
7 primary biliary cirrhosis 30.8 PDCD1 MIR326 MIR223 MIR20A MIR17 HLA-DRB1
8 severe cutaneous adverse reaction 30.7 PDCD1 HLA-DRB1 HLA-DQB1
9 primary adrenal insufficiency 30.7 HLA-DRB1 HLA-DQB1
10 autoimmune disease of central nervous system 30.6 MIR223 MIR142 HLA-DRB1
11 autoimmune hepatitis type 1 30.6 HLA-DRB1 HLA-DQB1
12 connective tissue disease 30.5 MIR223 MIR17 MIR145 MIR142 HLA-DRB1
13 pityriasis rosea 30.5 HLA-DRB1 HLA-DQB1
14 nervous system disease 30.3 MIR96 MIR223 MIR20A MIR17 MIR145 MIR142
15 rectum cancer 30.2 MIR20A MIR17 MIR145
16 esophageal disease 30.0 MIR223 MIR17 MIR145 MIR142
17 oral squamous cell carcinoma 30.0 MIR96 MIR223 MIR17 MIR145
18 endometriosis 30.0 MIR223 MIR20A MIR145 MIR142
19 diffuse large b-cell lymphoma 29.9 PDCD1 MIR17 MIR145 MIR142
20 eye disease 29.8 MIR223 MIR20B MIR20A MIR17 MIR142
21 pancreatic ductal adenocarcinoma 29.8 MIR96 MIR223 MIR145 MIR142
22 gastrointestinal system disease 29.7 MIR223 MIR20A MIR17 MIR145 MIR142
23 leukemia, chronic lymphocytic 29.7 MIR223 MIR20A MIR17 MIR145 MIR142
24 prostate disease 29.7 MIR223 MIR20A MIR17 MIR145 MIR142
25 arteries, anomalies of 29.6 MIR223 MIR17 MIR145 MIR142
26 intestinal disease 29.5 MIR20A MIR17 MIR145 MIR142
27 breast disease 29.5 MIR20A MIR17 MIR145 MIR142
28 bladder disease 29.4 MIR96 MIR17 MIR145 MIR142
29 lung cancer susceptibility 3 29.1 PDCD1 MIR96 MIR20B MIR17 MIR145 MIR142
30 cardiovascular system disease 29.1 MIR223 MIR17 MIR145 MIR142
31 immune system disease 28.5 MIR96 MIR223 MIR20B MIR20A MIR17 MIR145
32 relapsing-remitting multiple sclerosis 12.8
33 marburg acute multiple sclerosis 12.8
34 primary progressive multiple sclerosis 12.7
35 multiple sclerosis 5 12.7
36 secondary progressive multiple sclerosis 12.7
37 multiple sclerosis 3 12.7
38 progressive relapsing multiple sclerosis 12.6
39 multiple sclerosis 2 12.5
40 multiple sclerosis 4 12.4
41 multiple sclerosis-ichthyosis-factor viii deficiency syndrome 12.2
42 neuromyelitis optica 12.2
43 balo concentric sclerosis 12.1
44 leukodystrophy, demyelinating, adult-onset, autosomal dominant 12.1
45 autosomal dominant leukodystrophy with autonomic disease 11.9
46 optic neuritis 11.9
47 trigeminal neuralgia 11.7
48 spasticity 11.6
49 progressive multifocal leukoencephalopathy 11.6
50 leber optic atrophy 11.6
51 pars planitis 11.6
52 malonyl-coa decarboxylase deficiency 11.5
53 tremor 11.5
54 alexander disease 11.5
55 brown-sequard syndrome 11.5
56 acute disseminated encephalomyelitis 11.5
57 rickets 11.5
58 optic nerve disease 11.5
59 cerebral atrophy 11.5
60 neurogenic bladder 11.5
61 dysphagia 11.5
62 paresthesia 11.5
63 intermediate uveitis 11.4
64 pseudobulbar affect 11.4
65 foot drop 11.4
66 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 11.4
67 retinal vasculitis 11.4
68 myoclonus 11.4
69 hypertonia 11.4
70 neurogenic bowel 11.4
71 stiff-person syndrome 11.4
72 spinocerebellar degeneration 11.4
73 swallowing disorders 11.4
74 leukoencephalopathy, hereditary diffuse, with spheroids 11.4
75 locked-in syndrome 11.4
76 cerebellar degeneration 11.4
77 glossopharyngeal neuralgia 11.4
78 postinfectious encephalomyelitis 11.4
79 thoracic outlet syndrome 11.4
80 central pain syndrome 11.2
81 allergic encephalomyelitis 11.2
82 demyelinating disease 11.2
83 autoimmune disease 11.2
84 neuritis 11.1
85 thanatophoric dysplasia, type ii 11.1
86 bile acid synthesis defect, congenital, 2 11.1
87 methylmalonic aciduria and homocystinuria, cbld type 11.1
88 lathosterolosis 11.1
89 bile acid synthesis defect, congenital, 1 11.1
90 short qt syndrome 1 11.1
91 short qt syndrome 2 11.1
92 short qt syndrome 3 11.1
93 aminoacylase 1 deficiency 11.1
94 short qt syndrome 11.1
95 syndromic x-linked intellectual disability snyder type 11.1
96 autoimmune disease 6 11.1
97 combined malonic and methylmalonic aciduria 11.1
98 patulous eustachian tube 11.1
99 chiasmal syndrome 11.1
100 developmental coordination disorder 11.1
101 ataxias and cerebellar or spinocerebellar degeneration 11.1
102 immune-mediated encephalomyelitis 11.1
103 spinocerebellar atrophy 11.1
104 limbic encephalitis with lgi1 antibodies 10.9 HLA-DRB1 HLA-DQB1
105 autoimmune polyglandular syndrome type 3 10.9 HLA-DRB1 HLA-DQB1
106 narcolepsy 2 10.9 HLA-DRB1 HLA-DQB1
107 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.9
108 type ii mixed cryoglobulinemia 10.9 HLA-DRB1 HLA-DQB1
109 moyamoya angiopathy 10.9 HLA-DRB1 HLA-DQB1
110 recurrent respiratory papillomatosis 10.9 HLA-DRB1 HLA-DQB1
111 beryllium disease 10.9 HLA-DRB1 HLA-DQB1
112 apple allergy 10.9 HLA-DRB1 HLA-DQB1
113 chronic beryllium disease 10.9 HLA-DRB1 HLA-DQB1
114 measles 10.9
115 focal epithelial hyperplasia 10.9 HLA-DRB1 HLA-DQB1
116 metal allergy 10.8 HLA-DRB1 HLA-DQB1
117 narcolepsy 1 10.8 HLA-DRB1 HLA-DQB1
118 idiopathic bronchiectasis 10.8 HLA-DRB1 HLA-DQB1
119 osteonecrosis of the jaw 10.8 HLA-DRB1 HLA-DQB1
120 red cell aplasia 10.7 HLA-DRB1 HLA-DQB1
121 autoimmune disease of gastrointestinal tract 10.7 MIR223 HLA-DRB1 HLA-DQB1
122 venous insufficiency 10.7
123 ataxia and polyneuropathy, adult-onset 10.7
124 sexual disorder 10.7
125 cytokine deficiency 10.7
126 depression 10.7
127 myelitis 10.7
128 chickenpox 10.7
129 lateral sclerosis 10.6
130 amyotrophic lateral sclerosis 1 10.6
131 pathologic nystagmus 10.6
132 lymphopenia 10.6
133 rubella 10.6
134 migraine with or without aura 1 10.6
135 encephalitis 10.6
136 uveitis 10.6
137 neuropathy 10.6
138 anxiety 10.6
139 sleep disorder 10.6
140 oligoarticular juvenile idiopathic arthritis 10.6 HLA-DRB1 HLA-DQB1
141 subacute sclerosing panencephalitis 10.6
142 transverse myelitis 10.6
143 mood disorder 10.6
144 myasthenia gravis 10.5
145 spinal cord injury 10.5
146 autonomic dysfunction 10.5
147 kearns-sayre syndrome 10.5
148 pfeiffer syndrome 10.5
149 visual epilepsy 10.5
150 seizure disorder 10.5
151 mumps 10.5
152 headache 10.5
153 vasculitis 10.5
154 meester-loeys syndrome 10.5
155 ocular cicatricial pemphigoid 10.5 HLA-DRB1 HLA-DQB1
156 systemic lupus erythematosus 10.5
157 chronic pain 10.5
158 herpes simplex 10.5
159 chlamydia 10.5
160 internuclear ophthalmoplegia 10.5
161 spastic paraparesis 10.5
162 47,xyy 10.5
163 autoimmune encephalitis 10.5
164 acute retrobulbar neuritis 10.5
165 movement disease 10.5
166 chronic fatigue syndrome 10.5
167 pik3ca-related overgrowth syndrome 10.5
168 chlamydia pneumonia 10.5
169 bone inflammation disease 10.5 MIR223 MIR17 MIR142 HLA-DRB1
170 guillain-barre syndrome 10.5
171 constipation 10.5
172 restless legs syndrome 10.5
173 alzheimer disease 10.4
174 lupus erythematosus 10.4
175 proteasome-associated autoinflammatory syndrome 1 10.4
176 mental depression 10.4
177 dystonia 10.4
178 pustulosis of palm and sole 10.4
179 tetanus 10.4
180 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.4
181 inflammatory bowel disease 10.4
182 paraplegia 10.4
183 neutropenia 10.4
184 polyneuropathy 10.4
185 impotence 10.4
186 low compliance bladder 10.4
187 epilepsy 10.4
188 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.4
189 acute cystitis 10.4
190 bipolar disorder 10.4
191 major affective disorder 8 10.4
192 major affective disorder 9 10.4
193 covid-19 10.4
194 herpes zoster 10.4
195 encephalopathy 10.4
196 pleural cancer 10.4 MIR223 MIR17 MIR142
197 narcolepsy 10.4
198 hereditary optic neuropathy 10.4
199 major depressive disorder 10.4
200 exanthem 10.4
201 peripheral nervous system disease 10.4
202 body mass index quantitative trait locus 1 10.4
203 vascular disease 10.4
204 macular retinal edema 10.4
205 crohn's disease 10.4
206 48,xyyy 10.4
207 wallerian degeneration 10.4
208 whipple disease 10.3 HLA-DRB1 HLA-DQB1
209 hepatitis b 10.3
210 aphasia 10.3
211 hypothyroidism 10.3
212 candidiasis, familial, 1 10.3
213 thyroiditis 10.3
214 sarcoidosis 1 10.3
215 branchiootic syndrome 1 10.3
216 meningoencephalitis 10.3
217 dentinogenesis imperfecta type 2 10.3
218 meningitis 10.3
219 inflammatory spondylopathy 10.3
220 purpura 10.3
221 spondylitis 10.3
222 retinitis pigmentosa 18 10.3
223 spondyloarthropathy 1 10.3
224 huntington disease 10.3
225 parkinson disease, late-onset 10.3
226 sleep apnea 10.3
227 detrusor sphincter dyssynergia 10.3
228 facial paralysis 10.3
229 antiphospholipid syndrome 10.3
230 severe combined immunodeficiency 10.3
231 mature b-cell neoplasm 10.3 MIR20B MIR17 MIR142
232 pertussis 10.3
233 tropical spastic paraparesis 10.3
234 myelopathy, htlv-1-associated 10.3
235 rheumatoid arthritis 10.3
236 leukodystrophy 10.3
237 lyme disease 10.3
238 allergic hypersensitivity disease 10.3
239 amenorrhea 10.3
240 poliomyelitis 10.3
241 htlv-1 associated myelopathy/tropical spastic paraparesis 10.3
242 infratentorial cancer 10.3 MIR20A MIR17 MIR142
243 yemenite deaf-blind hypopigmentation syndrome 10.3
244 status epilepticus 10.3
245 chronic inflammatory demyelinating polyradiculoneuropathy 10.3
246 demyelinating polyneuropathy 10.3
247 alopecia 10.3
248 glial tumor 10.3
249 laryngeal disease 10.3 MIR20A MIR17 MIR142
250 thrombophilia due to thrombin defect 10.3
251 lymphoma 10.3
252 thrombocytopenia 10.3
253 vaccinia 10.3
254 glioma 10.3
255 dementia - subcortical 10.3
256 traumatic brain injury 10.3
257 gastrointestinal system benign neoplasm 10.3 MIR20A MIR17 MIR142
258 leukocyte disease 10.3 MIR17 MIR145 MIR142
259 celiac disease 1 10.3
260 hydrocephalus 10.3
261 brucellosis 10.3
262 atrioventricular block 10.3
263 sensorineural hearing loss 10.3
264 respiratory failure 10.3
265 aseptic meningitis 10.3
266 astrocytoma 10.3
267 ulcerative colitis 10.3
268 paroxysmal dystonia 10.3
269 isolated optic neuritis 10.3
270 osteoporosis 10.3
271 bone mineral density quantitative trait locus 8 10.3
272 bone mineral density quantitative trait locus 15 10.3
273 bullous pemphigoid 10.3
274 apraxia 10.2
275 graves' disease 10.2
276 3-methylglutaconic aciduria, type iii 10.2
277 alexithymia 10.2
278 bacterial infectious disease 10.2
279 hemiplegia 10.2
280 quadriplegia 10.2
281 dementia 10.2
282 glioblastoma multiforme 10.2
283 bone marrow cancer 10.2 MIR17 MIR145 MIR142
284 ovarian cancer 10.2
285 syringomyelia, noncommunicating isolated 10.2
286 aging 10.2
287 vitamin b12 deficiency 10.2
288 thrombocytopenia due to platelet alloimmunization 10.2
289 syringomyelia 10.2
290 fibromyalgia 10.2
291 pancreatic cancer 10.2
292 scleroderma, familial progressive 10.2
293 motor neuron disease 10.2
294 hyperthyroidism 10.2
295 back pain 10.2
296 cerebrofacial arteriovenous metameric syndrome 10.2
297 seizures, benign familial neonatal, 1 10.2
298 familial mediterranean fever 10.2
299 stroke, ischemic 10.2
300 spinal cord disease 10.2
301 viral encephalitis 10.2
302 iridocyclitis 10.2
303 ovary epithelial cancer 10.2 MIR18B MIR17 MIR145
304 hepatitis 10.2
305 neurofibromatosis 10.2
306 adrenomyeloneuropathy 10.2
307 argyria 10.2
308 malignant ovarian surface epithelial-stromal neoplasm 10.2 MIR18B MIR17 MIR145
309 connective tissue cancer 10.2 MIR223 MIR17 MIR145 MIR142
310 psychotic disorder 10.2
311 severe acute respiratory syndrome 10.2
312 oligodendroglioma 10.2
313 neurosarcoidosis 10.2
314 personality disorder 10.2
315 cerebral palsy 10.2
316 cerebrovascular disease 10.2
317 lung disease 10.2
318 hypereosinophilic syndrome 10.2
319 bile duct adenocarcinoma 10.2 MIR20B MIR17 MIR145 MIR142
320 bile duct disease 10.2 MIR20B MIR17 MIR145 MIR142
321 biliary tract disease 10.2 MIR20B MIR17 MIR145 MIR142
322 pharynx cancer 10.2 MIR17 MIR145 MIR142
323 intestinal benign neoplasm 10.2 MIR20A MIR17 MIR145 MIR142
324 multiple self-healing squamous epithelioma 10.2
325 adrenoleukodystrophy 10.2
326 body mass index quantitative trait locus 11 10.2
327 hyperprolactinemia 10.2
328 colitis 10.2
329 pulmonary edema 10.2
330 alcohol use disorder 10.2
331 central nervous system lymphoma 10.2
332 head injury 10.2
333 glucose metabolism disease 10.2 MIR223 MIR20A MIR17 MIR142
334 fatty liver disease 10.1
335 acquired metabolic disease 10.1 MIR223 MIR20A MIR17 MIR142
336 schizophrenia 10.1
337 chorea, childhood-onset, with psychomotor retardation 10.1
338 deficiency anemia 10.1
339 amnestic disorder 10.1
340 choreatic disease 10.1
341 diarrhea 10.1
342 panniculitis 10.1
343 dysgraphia 10.1
344 congestive heart failure 10.1
345 b-cell lymphoma 10.1
346 t-cell lymphoblastic leukemia/lymphoma 10.1
347 intracranial hypertension 10.1
348 leukemia, t-cell, chronic 10.1
349 primary central nervous system lymphoma 10.1
350 brain injury 10.1
351 acute transverse myelitis 10.1
352 methylmalonic acidemia 10.1
353 uterine anomalies 10.1 MIR20B MIR17 MIR145 MIR142
354 alcohol dependence 10.1
355 ocular motor apraxia 10.1
356 sjogren syndrome 10.1
357 helicobacter pylori infection 10.1
358 body mass index quantitative trait locus 9 10.1
359 body mass index quantitative trait locus 8 10.1
360 body mass index quantitative trait locus 4 10.1
361 body mass index quantitative trait locus 10 10.1
362 body mass index quantitative trait locus 7 10.1
363 hepatitis c virus 10.1
364 body mass index quantitative trait locus 12 10.1
365 body mass index quantitative trait locus 14 10.1
366 body mass index quantitative trait locus 18 10.1
367 body mass index quantitative trait locus 19 10.1
368 body mass index quantitative trait locus 20 10.1
369 aspiration pneumonia 10.1
370 nasopharyngitis 10.1
371 panuveitis 10.1
372 hemosiderosis 10.1
373 acute leukemia 10.1
374 disease of mental health 10.1
375 spondylosis 10.1
376 myopathy 10.1
377 polyradiculoneuropathy 10.1
378 acquired immunodeficiency syndrome 10.1
379 influenza 10.1
380 rare hereditary hemochromatosis 10.1
381 thrombotic microangiopathy 10.1
382 colonic disease 10.1 MIR20A MIR17 MIR145 MIR142
383 prostatic hyperplasia, benign 10.1
384 mucopolysaccharidosis-plus syndrome 10.1
385 prostatic adenoma 10.1
386 atrial standstill 1 10.1
387 obsessive-compulsive disorder 10.1
388 immune deficiency disease 10.1
389 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.1
390 fabry disease 10.1
391 meningioma, radiation-induced 10.1
392 meningioma, familial 10.1
393 pain agnosia 10.1
394 agraphia 10.1
395 thrombosis 10.1
396 spinal meningioma 10.1
397 dental caries 10.1
398 dermatitis 10.1
399 skin carcinoma 10.1
400 systemic scleroderma 10.1
401 neuromuscular disease 10.1
402 secretory meningioma 10.1
403 lymphoplasmacyte-rich meningioma 10.1
404 essential tremor 10.1
405 myeloid leukemia 10.1
406 muscular dystrophy 10.1
407 dysautonomia 10.1
408 non-alcoholic fatty liver disease 10.1
409 isolated methylmalonic acidemia 10.1
410 phenylketonuria 10.1
411 dysentery 10.1
412 mucopolysaccharidoses 10.1
413 hypercholesterolemia, familial, 1 10.1
414 spondylosis, cervical 10.1
415 triiodothyronine receptor auxiliary protein 10.1
416 lymphoma, hodgkin, classic 10.1
417 bone mineral density quantitative trait locus 3 10.1
418 human immunodeficiency virus type 1 10.1
419 microvascular complications of diabetes 5 10.1
420 asymptomatic neurosyphilis 10.1
421 leukemia 10.1
422 avoidant personality disorder 10.1
423 enthesopathy 10.1
424 thyroid gland disease 10.1
425 diabetes mellitus 10.1
426 neurosyphilis 10.1
427 pure autonomic failure 10.1
428 sudden sensorineural hearing loss 10.1
429 autonomic nervous system neoplasm 10.1 MIR20A MIR17 MIR142
430 tyrosinemia 10.1
431 major affective disorder 1 10.1
432 hand skill, relative 10.1
433 pulmonary hypertension, primary, 1 10.1
434 taqi polymorphism 10.1
435 orthostatic intolerance 10.1
436 acute promyelocytic leukemia 10.1
437 cervical dystonia 10.1
438 neuroretinitis 10.1
439 charcot-marie-tooth disease 10.1
440 diphtheria 10.1
441 color blindness 10.1
442 alexia 10.1
443 urticaria 10.1
444 retinal vascular disease 10.1
445 ischemia 10.1
446 radiculopathy 10.1
447 infertility 10.1
448 hemolytic anemia 10.1
449 juvenile rheumatoid arthritis 10.1
450 rem sleep behavior disorder 10.1
451 speech disorder 10.1
452 scotoma 10.1
453 viral infectious disease 10.1
454 bacterial meningitis 10.1
455 pulmonary embolism 10.1
456 cluster headache 10.1
457 syncope 10.1
458 inflammatory myopathy with abundant macrophages 10.1
459 pachyonychia congenita 3 10.0
460 polycystic ovary syndrome 10.0
461 ovarian epithelial cancer 10.0
462 acyl-coa dehydrogenase deficiency 10.0
463 creutzfeldt-jakob disease 10.0
464 vitiligo-associated multiple autoimmune disease susceptibility 6 10.0
465 leukemia, acute myeloid 10.0
466 vitiligo-associated multiple autoimmune disease susceptibility 1 10.0
467 intraocular pressure quantitative trait locus 10.0
468 graft-versus-host disease 10.0
469 melanoma, cutaneous malignant 10 10.0
470 tick-borne encephalitis 10.0
471 lymphoproliferative syndrome 10.0
472 viral meningitis 10.0
473 hydronephrosis 10.0
474 pyelonephritis 10.0
475 nephrotic syndrome 10.0
476 bell's palsy 10.0
477 migraine without aura 10.0
478 generalized anxiety disorder 10.0
479 hepatitis c 10.0
480 melanoma 10.0
481 hyperinsulinism 10.0
482 hereditary spastic paraplegia 10.0
483 syphilis 10.0
484 nephrolithiasis 10.0
485 muscular atrophy 10.0
486 irritable bowel syndrome 10.0
487 hypoxia 10.0
488 acute liver failure 10.0
489 peripheral nervous system neoplasm 10.0 MIR20A MIR17 MIR142
490 prostate cancer 10.0
491 adenocarcinoma 10.0
492 hemifacial spasm, familial 10.0
493 thrombocytopenic purpura, autoimmune 10.0
494 torticollis 10.0
495 homocysteinemia 10.0
496 psoriatic arthritis 10.0
497 crohn's colitis 10.0
498 bone resorption disease 10.0
499 physical disorder 10.0
500 tooth disease 10.0
501 horner's syndrome 10.0
502 gout 10.0
503 cerebellar disease 10.0
504 neurotic disorder 10.0
505 scrapie 10.0
506 mitochondrial disorders 10.0
507 raynaud phenomenon 10.0
508 cytomegalovirus infection 10.0
509 hemifacial spasm 10.0
510 invasive aspergillosis 10.0
511 opioid abuse 10.0
512 oral cancer 10.0
513 kaposi sarcoma 10.0
514 graves disease 1 10.0
515 coronary heart disease 1 10.0
516 leukemia, acute lymphoblastic 10.0
517 leukemia, acute lymphoblastic 3 10.0
518 spinal disease 10.0
519 optic papillitis 10.0
520 pre-eclampsia 10.0
521 thrombotic thrombocytopenic purpura 10.0
522 rabies 10.0
523 arteriovenous malformation 10.0
524 posterior uveitis 10.0
525 toxic shock syndrome 10.0
526 cystitis 10.0
527 viral hepatitis 10.0
528 iron metabolism disease 10.0
529 sensory peripheral neuropathy 10.0
530 substance abuse 10.0
531 retinitis 10.0
532 agnosia 10.0
533 placenta disease 10.0
534 cataract 10.0
535 arthritis 10.0
536 subacute delirium 10.0
537 polyarteritis nodosa 10.0
538 toxoplasmosis 10.0
539 acquired hemophilia 10.0
540 broken heart syndrome 10.0
541 herpes simplex encephalitis 10.0
542 polymyositis 10.0
543 propionic acidemia 10.0
544 silicosis 10.0
545 mastitis 10.0
546 urinary system disease 10.0 MIR223 MIR20B MIR17 MIR145 MIR142
547 reproductive system disease 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
548 lymphatic system cancer 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
549 large intestine cancer 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
550 esophageal cancer 10.0
551 maple syrup urine disease 10.0
552 foodborne botulism 10.0
553 sleeping sickness 10.0
554 peroxisomal disease 10.0
555 soft tissue sarcoma 10.0
556 respiratory system cancer 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
557 female reproductive system disease 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
558 thoracic cancer 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
559 respiratory system disease 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
560 abducens palsy 10.0
561 atherosclerosis susceptibility 10.0
562 multiple system atrophy 1 10.0
563 neurofibromatosis, type i 10.0
564 anemia, autoimmune hemolytic 10.0
565 diabetes mellitus, type i 10.0
566 hemochromatosis, type 1 10.0
567 metachromatic leukodystrophy 10.0
568 spondylometaphyseal dysplasia, sedaghatian type 10.0
569 nasopharyngeal carcinoma 10.0
570 resting heart rate, variation in 10.0
571 myelodysplastic syndrome 10.0
572 juvenile arthritis 10.0
573 ptosis 10.0
574 cryptococcal meningitis 10.0
575 t cell deficiency 10.0
576 dysthymic disorder 10.0
577 retinal ischemia 10.0
578 bacteriuria 10.0
579 normal pressure hydrocephalus 10.0
580 hypogonadism 10.0
581 tic disorder 10.0
582 newcastle disease 10.0
583 lipid metabolism disorder 10.0
584 liver cirrhosis 10.0
585 diabetes insipidus 10.0
586 yellow fever 10.0
587 aids dementia complex 10.0
588 haemophilus influenzae 10.0
589 human t-cell leukemia virus type 1 10.0
590 susac syndrome 10.0
591 systemic autoimmune disease 10.0
592 rapidly involuting congenital hemangioma 10.0
593 specific language disorder 10.0
594 benign idiopathic neonatal seizures 10.0
595 overgrowth syndrome 10.0
596 gastrointestinal system cancer 10.0 MIR223 MIR20A MIR17 MIR145 MIR142
597 hypertension, essential 9.9
598 acyl-coa dehydrogenase, medium-chain, deficiency of 9.9
599 isovaleric acidemia 9.9
600 smith-lemli-opitz syndrome 9.9
601 opitz gbbb syndrome, type i 9.9
602 fatty liver disease, nonalcoholic 1 9.9
603 carbonic anhydrase va deficiency, hyperammonemia due to 9.9
604 non-alcoholic steatohepatitis 9.9
605 trypanosomiasis 9.9
606 common cold 9.9
607 opiate dependence 9.9
608 ige responsiveness, atopic 9.9
609 papillomatosis, confluent and reticulated 9.9
610 complement component 2 deficiency 9.9
611 kuru 9.9
612 biotinidase deficiency 9.9
613 insulin-like growth factor i 9.9
614 cd4/cd8 t-cell ratio 9.9
615 pulmonary disease, chronic obstructive 9.9
616 human herpesvirus 8 9.9
617 peripheral vascular disease 9.9
618 interleukin-7 receptor alpha deficiency 9.9
619 postural orthostatic tachycardia syndrome 9.9
620 endocarditis 9.9
621 listeriosis 9.9
622 gastroparesis 9.9
623 cryptococcosis 9.9
624 goiter 9.9
625 pancytopenia 9.9
626 chronic progressive external ophthalmoplegia 9.9
627 keratoconjunctivitis sicca 9.9
628 dissociated nystagmus 9.9
629 porphyria 9.9
630 autosomal dominant cerebellar ataxia 9.9
631 rheumatic fever 9.9
632 conversion disorder 9.9
633 hairy cell leukemia 9.9
634 grade iii astrocytoma 9.9
635 neurilemmoma 9.9
636 inappropriate adh syndrome 9.9
637 thrombophlebitis 9.9
638 pyoderma 9.9
639 rhinitis 9.9
640 benign ependymoma 9.9
641 cellular ependymoma 9.9
642 pneumonia 9.9
643 kidney disease 9.9
644 panic disorder 9.9
645 adenoma 9.9
646 neuroblastoma 9.9
647 end stage renal disease 9.9
648 collagen disease 9.9
649 vascular dementia 9.9
650 stomatitis 9.9
651 diabetic neuropathy 9.9
652 alopecia areata 9.9
653 central serous chorioretinopathy 9.9
654 granulocytopenia 9.9
655 aneurysm 9.9
656 occipital neuralgia 9.9
657 posttransplant acute limbic encephalitis 9.9
658 paroxysmal dyskinesia 9.9
659 avascular necrosis 9.9
660 epilepsy, pyridoxine-dependent 9.9
661 tyrosinemia, type i 9.9
662 citrullinemia, type ii, adult-onset 9.9
663 autoimmune lymphoproliferative syndrome, type v 9.9
664 metabolic acidosis 9.9
665 organic acidemia 9.9
666 multidrug-resistant tuberculosis 9.9
667 anthrax disease 9.9
668 ciguatera fish poisoning 9.9
669 mycobacterium abscessus 9.9
670 hematologic cancer 9.9 MIR223 MIR20A MIR17 MIR145 MIR142
671 aortic aneurysm, familial abdominal, 1 9.9
672 acyl-coa dehydrogenase, short-chain, deficiency of 9.9
673 galactosemia i 9.9
674 microvascular complications of diabetes 1 9.9
675 microvascular complications of diabetes 2 9.9
676 ductal carcinoma in situ 9.9
677 aortic aneurysm 9.9
678 pancreatic adenocarcinoma 9.9
679 avian influenza 9.9
680 dermatophytosis 9.9
681 medium-chain acyl-coenzyme a dehydrogenase deficiency 9.9
682 disseminated infection with mycobacterium avium complex 9.9
683 bladder cancer 9.9
684 burkitt lymphoma 9.9
685 deafness, unilateral 9.9
686 episodic kinesigenic dyskinesia 1 9.9
687 pernicious anemia 9.9
688 pelvic organ prolapse 9.9
689 retinal detachment 9.9
690 spinal arachnoiditis 9.9
691 vesicoureteral reflux 1 9.9
692 autism 9.9
693 galactorrhea 9.9
694 reticulum cell sarcoma 9.9
695 pelizaeus-merzbacher disease 9.9
696 frontotemporal dementia 9.9
697 autoimmune lymphoproliferative syndrome 9.9
698 lymphoma, non-hodgkin, familial 9.9
699 myocardial infarction 9.9
700 membranous nephropathy 9.9
701 glucocorticoid resistance, generalized 9.9
702 adult t-cell leukemia 9.9
703 second-degree atrioventricular block 9.9
704 spastic ataxia 9.9
705 immunoglobulin alpha deficiency 9.9
706 cutaneous t cell lymphoma 9.9
707 atrial fibrillation 9.9
708 nodal marginal zone lymphoma 9.9
709 migraine with aura 9.9
710 osteonecrosis 9.9
711 abducens nerve disease 9.9
712 choroiditis 9.9
713 gestational diabetes 9.9
714 arachnoiditis 9.9
715 pseudobulbar palsy 9.9
716 telangiectasis 9.9
717 transient global amnesia 9.9
718 brain cancer 9.9
719 pulmonary sarcoidosis 9.9
720 eclampsia 9.9
721 premature ejaculation 9.9
722 squamous cell papilloma 9.9
723 obstructive hydrocephalus 9.9
724 endogenous depression 9.9
725 pericarditis 9.9
726 gastroenteritis 9.9
727 thrombophilia 9.9
728 hemangioma 9.9
729 papilloma 9.9
730 acute pancreatitis 9.9
731 glomerulonephritis 9.9
732 food allergy 9.9
733 cranial nerve palsy 9.9
734 gastritis 9.9
735 liver disease 9.9
736 brain edema 9.9
737 adjustment disorder 9.9
738 central nervous system vasculitis 9.9
739 blepharospasm 9.9
740 cerebral lymphoma 9.9
741 central pontine myelinolysis 9.9
742 mitochondrial metabolism disease 9.9
743 myocarditis 9.9
744 amyloidosis 9.9
745 pemphigus 9.9
746 hypoglycemia 9.9
747 charles bonnet syndrome 9.9
748 chiari malformation 9.9
749 eales disease 9.9
750 engraftment syndrome 9.9
751 limbic encephalitis 9.9
752 myalgic encephalomyelitis/chronic fatigue syndrome 9.9
753 myelinoclastic diffuse sclerosis 9.9
754 periodic paralysis 9.9
755 dowling-degos disease 1 9.8
756 retinoblastoma 9.8
757 dihydropyrimidine dehydrogenase deficiency 9.8
758 dengue virus 9.8
759 mantle cell lymphoma 9.8
760 biotin deficiency 9.8
761 estrogen-receptor positive breast cancer 9.8
762 pleurisy 9.8
763 sphingolipidosis 9.8
764 familial retinoblastoma 9.8
765 cocaine abuse 9.8
766 zellweger syndrome 9.8
767 creatine deficiency syndromes 9.8
768 cyanide poisoning 9.8
769 motion sickness 9.8
770 osteogenic sarcoma 9.8
771 mucopolysaccharidosis, type ii 9.8
772 citrullinemia, type ii, neonatal-onset 9.8
773 isobutyryl-coa dehydrogenase deficiency 9.8
774 adenine phosphoribosyltransferase deficiency 9.8
775 colorectal adenocarcinoma 9.8
776 osteomyelitis 9.8
777 chagas disease 9.8
778 colon adenocarcinoma 9.8
779 arteriosclerosis 9.8
780 hemoglobinopathy 9.8
781 breast adenocarcinoma 9.8
782 mouth disease 9.8
783 multiple carboxylase deficiency 9.8
784 cannabis abuse 9.8
785 congenital disorders of n-linked glycosylation and multiple pathway 9.8
786 homocystinuria caused by cystathionine beta-synthase deficiency 9.8
787 neisseria meningitidis infection 9.8
788 opioid addiction 9.8
789 paraquat poisoning 9.8
790 colchicine poisoning 9.8
791 cerebral amyloid angiopathy, cst3-related 9.8
792 breast cancer 9.8
793 cardiac conduction defect 9.8
794 hepatocellular carcinoma 9.8
795 attention deficit-hyperactivity disorder 9.8
796 lipomatosis, multiple 9.8
797 myositis 9.8
798 optic atrophy 1 9.8
799 nephrolithiasis, calcium oxalate 9.8
800 hypokalemic periodic paralysis, type 1 9.8
801 strabismus 9.8
802 tobacco addiction 9.8
803 lung cancer 9.8
804 cerebrotendinous xanthomatosis 9.8
805 factor vii deficiency 9.8
806 moyamoya disease 1 9.8
807 myeloma, multiple 9.8
808 vitamin d hydroxylation-deficient rickets, type 1a 9.8
809 properdin deficiency, x-linked 9.8
810 asthma 9.8
811 xanthomatosis 9.8
812 spastic paraplegia 11, autosomal recessive 9.8
813 acute hemorrhagic leukoencephalitis 9.8
814 allergic rhinitis 9.8
815 kala-azar 1 9.8
816 aspergillosis 9.8
817 joint laxity, short stature, and myopia 9.8
818 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.8
819 speech and communication disorders 9.8
820 angina pectoris 9.8
821 pulmonary hypertension 9.8
822 hemophagocytic lymphohistiocytosis 9.8
823 swine influenza 9.8
824 first-degree atrioventricular block 9.8
825 hemidystonia 9.8
826 anosognosia 9.8
827 cortical deafness 9.8
828 bone disease 9.8
829 middle east respiratory syndrome 9.8
830 cysticercosis 9.8
831 xerophthalmia 9.8
832 pleomorphic lipoma 9.8
833 dermatomyositis 9.8
834 brown's tendon sheath syndrome 9.8
835 siderosis 9.8
836 tonsillitis 9.8
837 sarcoma 9.8
838 social phobia 9.8
839 heart disease 9.8
840 listeria meningitis 9.8
841 iron deficiency anemia 9.8
842 myopia 9.8
843 bronchopneumonia 9.8
844 hepatitis a 9.8
845 hemolytic-uremic syndrome 9.8
846 leiomyoma 9.8
847 ocular motility disease 9.8
848 miller fisher syndrome 9.8
849 focal segmental glomerulosclerosis 9.8
850 ehlers-danlos syndrome 9.8
851 frozen shoulder 9.8
852 neuroleptic malignant syndrome 9.8
853 hyperuricemia 9.8
854 neuroma 9.8
855 post-traumatic stress disorder 9.8
856 focal epilepsy 9.8
857 basal cell carcinoma 9.8
858 agammaglobulinemia 9.8
859 bruxism 9.8
860 pulmonary tuberculosis 9.8
861 bursitis 9.8
862 acute kidney failure 9.8
863 churg-strauss syndrome 9.8
864 gingivitis 9.8
865 complex regional pain syndrome 9.8
866 histiocytosis 9.8
867 plexopathy 9.8
868 skin disease 9.8
869 pituitary adenoma 9.8
870 merkel cell carcinoma 9.8
871 mutism 9.8
872 spindle cell sarcoma 9.8
873 dyslexia 9.8
874 postpoliomyelitis syndrome 9.8
875 gerstmann syndrome 9.8
876 borna disease 9.8
877 schizoaffective disorder 9.8
878 acute stress disorder 9.8
879 subacute thyroiditis 9.8
880 axonal neuropathy 9.8
881 periodontitis 9.8
882 ileus 9.8
883 paralytic ileus 9.8
884 retinal degeneration 9.8
885 reticulosarcoma 9.8
886 pyoderma gangrenosum 9.8
887 decubitus ulcer 9.8
888 leishmaniasis 9.8
889 periodic limb movement disorder 9.8
890 central sleep apnea 9.8
891 homocystinuria 9.8
892 ocular hypertension 9.8
893 priapism 9.8
894 mechanical strabismus 9.8
895 fasciitis 9.8
896 allergic angiitis 9.8
897 chronic graft versus host disease 9.8
898 mast cell activation syndrome 9.8
899 oligoastrocytoma 9.8
900 primary angiitis of the central nervous system 9.8
901 reversible cerebral vasoconstriction syndrome 9.8
902 tuberculous meningitis 9.8
903 x-linked charcot-marie-tooth disease 9.8
904 color vision deficiency 9.8
905 anoxia 9.8
906 hypotonia 9.8
907 meningitis and encephalitis 9.8
908 myotonia 9.8
909 superficial siderosis 9.8
910 cranial neuralgia 9.8
911 hypocalcemic vitamin d-dependent rickets 9.8
912 chronic enteropathy associated with slco2a1 gene 9.8
913 persistent idiopathic facial pain 9.8
914 chronic encephalitis 9.8
915 cardiogenic shock 9.8
916 thyroid carcinoma 9.8
917 beckwith-wiedemann syndrome 9.8
918 neural tube defects 9.8
919 thyroid cancer, nonmedullary, 1 9.8
920 adrenocortical carcinoma, hereditary 9.8
921 apparent mineralocorticoid excess 9.8
922 hydrops fetalis, nonimmune 9.8
923 n-acetylglutamate synthase deficiency 9.8
924 autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia 9.8
925 galactosialidosis 9.8
926 pancreatic agenesis 1 9.8
927 ornithine transcarbamylase deficiency, hyperammonemia due to 9.8
928 2-methylbutyryl-coa dehydrogenase deficiency 9.8
929 pyridoxamine 5-prime-phosphate oxidase deficiency 9.8
930 cerebral creatine deficiency syndrome 2 9.8
931 melioidosis 9.8
932 mulchandani-bhoj-conlin syndrome 9.8
933 adrenal cortical carcinoma 9.8
934 chikungunya 9.8
935 inhalation anthrax 9.8
936 androgenic alopecia 9.8
937 chronic venous insufficiency 9.8
938 idiopathic scoliosis 9.8
939 peroxisomal biogenesis disorder 9.8
940 asbestosis 9.8
941 lactose intolerance 9.8
942 methemoglobinemia 9.8
943 filariasis 9.8
944 familial hyperlipidemia 9.8
945 biliary atresia 9.8
946 dumping syndrome 9.8
947 larynx cancer 9.8
948 pancreas disease 9.8
949 periarthritis 9.8
950 adrenal cortical adenocarcinoma 9.8
951 endophthalmitis 9.8
952 amphetamine abuse 9.8
953 peptic ulcer disease 9.8
954 polycythemia 9.8
955 cervix uteri carcinoma in situ 9.8
956 acid sphingomyelinase deficiency 9.8
957 cervical intraepithelial neoplasia 9.8
958 ring chromosome 13 9.8
959 systemic onset juvenile idiopathic arthritis 9.8
960 asbestos intoxication 9.8
961 manganese poisoning 9.8
962 facial spasm 9.7
963 hair whorl 9.7
964 charcot-marie-tooth disease, demyelinating, type 1a 9.7
965 colorectal cancer 9.7
966 b-cell growth factor 9.7
967 machado-joseph disease 9.7
968 renal cell carcinoma, nonpapillary 9.7
969 hypertelorism 9.7
970 hypertriglyceridemia, familial 9.7
971 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1 9.7
972 pheochromocytoma 9.7
973 polykaryocytosis inducer 9.7
974 schistosoma mansoni infection, susceptibility/ 9.7
975 spastic paraplegia 4, autosomal dominant 9.7
976 suppressor of tumorigenicity 3 9.7
977 urate oxidase, pseudogene 9.7
978 vasculitis, lymphocytic, nodular 9.7
979 lipoid congenital adrenal hyperplasia 9.7
980 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.7
981 alopecia universalis congenita 9.7
982 takayasu arteritis 9.7
983 ataxia-telangiectasia 9.7
984 eosinophilic fasciitis 9.7
985 hutterite cerebroosteonephrodysplasia syndrome 9.7
986 intracranial hypertension, idiopathic 9.7
987 krabbe disease 9.7
988 mycosis fungoides 9.7
989 sudanophilic cerebral sclerosis 9.7
990 sudden infant death syndrome 9.7
991 thymoma, familial 9.7
992 wilson disease 9.7
993 fragile x tremor/ataxia syndrome 9.7
994 tubulin, beta 9.7
995 hemophilia a 9.7
996 spastic paraplegia 2, x-linked 9.7
997 retinitis pigmentosa 11 9.7
998 astigmatism 9.7
999 reflex sympathetic dystrophy 9.7
1000 langerhans cell histiocytosis 9.7
1001 anorexia nervosa 9.7
1002 spastic paraplegia 7, autosomal recessive 9.7
1003 mycobacterium tuberculosis 1 9.7
1004 leukemia, chronic myeloid 9.7
1005 phobia, specific 9.7
1006 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 2 9.7
1007 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 4 9.7
1008 west nile virus 9.7
1009 malaria 9.7
1010 smoking as a quantitative trait locus 3 9.7
1011 gastric cancer 9.7
1012 riboflavin deficiency 9.7
1013 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 9.7
1014 alacrima, achalasia, and mental retardation syndrome 9.7
1015 striatal degeneration, autosomal dominant 2 9.7
1016 hyperlipoproteinemia, type iii 9.7
1017 drug-induced lupus erythematosus 9.7
1018 familial adenomatous polyposis 9.7
1019 usher syndrome 9.7
1020 epidemic typhus 9.7
1021 female breast cancer 9.7
1022 autosomal recessive disease 9.7
1023 anaplastic large cell lymphoma 9.7
1024 rheumatic heart disease 9.7
1025 focal dystonia 9.7
1026 hemorrhagic cystitis 9.7
1027 fragile x-associated tremor/ataxia syndrome 9.7
1028 adrenal gland pheochromocytoma 9.7
1029 autosomal recessive cerebellar ataxia 9.7
1030 infective endocarditis 9.7
1031 withdrawal disorder 9.7
1032 autism spectrum disorder 9.7
1033 brain meningioma 9.7
1034 auditory agnosia 9.7
1035 lymphocytic colitis 9.7
1036 scoliosis 9.7
1037 drug allergy 9.7
1038 intestinal pseudo-obstruction 9.7
1039 urolithiasis 9.7
1040 hypogonadotropic hypogonadism 9.7
1041 thalassemia 9.7
1042 parotitis 9.7
1043 suppression amblyopia 9.7
1044 amblyopia 9.7
1045 open-angle glaucoma 9.7
1046 depersonalization disorder 9.7
1047 spondyloarthropathy 9.7
1048 ornithosis 9.7
1049 pneumocystosis 9.7
1050 mitral valve insufficiency 9.7
1051 cortical blindness 9.7
1052 coronary thrombosis 9.7
1053 pica disease 9.7
1054 lymphocytic choriomeningitis 9.7
1055 paranoid schizophrenia 9.7
1056 vogt-koyanagi-harada disease 9.7
1057 hepatic coma 9.7
1058 vestibular neuronitis 9.7
1059 acoustic neuroma 9.7
1060 dilated cardiomyopathy 9.7
1061 typhoid fever 9.7
1062 scrub typhus 9.7
1063 tuberous sclerosis 9.7
1064 hyperparathyroidism 9.7
1065 facial neuralgia 9.7
1066 benign paroxysmal positional nystagmus 9.7
1067 schistosomiasis 9.7
1068 algoneurodystrophy 9.7
1069 iritis 9.7
1070 vestibular nystagmus 9.7
1071 azoospermia 9.7
1072 candidiasis 9.7
1073 communicating hydrocephalus 9.7
1074 pneumothorax 9.7
1075 heart septal defect 9.7
1076 retinal vein occlusion 9.7
1077 mitral valve stenosis 9.7
1078 drug-induced hepatitis 9.7
1079 myotonia congenita 9.7
1080 b cell deficiency 9.7
1081 transient cerebral ischemia 9.7
1082 wernicke encephalopathy 9.7
1083 granulomatous angiitis 9.7
1084 benign mesothelioma 9.7
1085 melancholia 9.7
1086 membranoproliferative glomerulonephritis 9.7
1087 testicular cancer 9.7
1088 papillary carcinoma 9.7
1089 acute porphyria 9.7
1090 lysosomal storage disease 9.7
1091 thymoma 9.7
1092 germinoma 9.7
1093 temporal lobe epilepsy 9.7
1094 lateral medullary syndrome 9.7
1095 toxic encephalopathy 9.7
1096 kallmann syndrome 9.7
1097 arthropathy 9.7
1098 craniopharyngioma 9.7
1099 gait apraxia 9.7
1100 milk allergy 9.7
1101 myofibroma 9.7
1102 nominal aphasia 9.7
1103 retrograde amnesia 9.7
1104 ideomotor apraxia 9.7
1105 cavernous hemangioma 9.7
1106 pancreatitis 9.7
1107 subependymal giant cell astrocytoma 9.7
1108 copper deficiency myelopathy 9.7
1109 human immunodeficiency virus infectious disease 9.7
1110 spinal cord ependymoma 9.7
1111 agoraphobia 9.7
1112 bronchitis 9.7
1113 conjunctivitis 9.7
1114 prion disease 9.7
1115 inherited metabolic disorder 9.7
1116 capgras syndrome 9.7
1117 spinal stenosis 9.7
1118 premenstrual tension 9.7
1119 monoclonal gammopathy of uncertain significance 9.7
1120 delusional disorder 9.7
1121 chronic kidney disease 9.7
1122 peritonitis 9.7
1123 appendicitis 9.7
1124 osteoarthritis 9.7
1125 cyclothymic disorder 9.7
1126 genital herpes 9.7
1127 in situ carcinoma 9.7
1128 smallpox 9.7
1129 bacterial pneumonia 9.7
1130 mitochondrial encephalomyopathy 9.7
1131 learning disability 9.7
1132 cutaneous leishmaniasis 9.7
1133 erythromelalgia 9.7
1134 keratoconjunctivitis 9.7
1135 cholangitis 9.7
1136 refractive error 9.7
1137 peripheral vertigo 9.7
1138 hemophilia 9.7
1139 myotonic dystrophy 9.7
1140 bap1 tumor predisposition syndrome 9.7
1141 spastic paraplegia 4 9.7
1142 spastic paraplegia 11 9.7
1143 acquired hemophilia a 9.7
1144 alien hand syndrome 9.7
1145 autoimmune retinopathy 9.7
1146 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids 9.7
1147 hyperacusis 9.7
1148 lymphomatoid papulosis 9.7
1149 mercury poisoning 9.7
1150 mollaret meningitis 9.7
1151 paraneoplastic cerebellar degeneration 9.7
1152 post-transplant lymphoproliferative disease 9.7
1153 propriospinal myoclonus 9.7
1154 pustular psoriasis 9.7
1155 ring chromosome 5 9.7
1156 spasmodic dysphonia 9.7
1157 stevens-johnson syndrome/toxic epidermal necrolysis 9.7
1158 superficial siderosis of the central nervous system 9.7
1159 cerebral aneurysms 9.7
1160 deep brain stimulation for movement disorders 9.7
1161 hereditary neuropathies 9.7
1162 subcortical arteriosclerotic encephalopathy 9.7
1163 idiopathic acute transverse myelitis 9.7
1164 perioral myoclonia with absences 9.7
1165 progressive muscular dystrophy 9.7
1166 acute encephalopathy with biphasic seizures and late reduced diffusion 9.7
1167 chronic relapsing inflammatory optic neuropathy 9.7
1168 microcystic stromal tumor 9.7
1169 rubella panencephalitis 9.7
1170 autoinflammatory syndrome 9.7
1171 glioma susceptibility 1 9.7
1172 chlorpropamide-alcohol flushing 9.7
1173 progressive familial heart block, type ia 9.7
1174 hyperaldosteronism, familial, type i 9.7
1175 silver-russell syndrome 1 9.7
1176 argininosuccinic aciduria 9.7
1177 dihydropyrimidinase deficiency 9.7
1178 fucosidosis 9.7
1179 multiple acyl-coa dehydrogenase deficiency 9.7
1180 sandhoff disease 9.7
1181 canavan disease 9.7
1182 uruguay faciocardiomusculoskeletal syndrome 9.7
1183 barth syndrome 9.7
1184 menkes disease 9.7
1185 gallbladder disease 1 9.7
1186 ventricular fibrillation, paroxysmal familial, 1 9.7
1187 mevalonic aciduria 9.7
1188 alopecia, neurologic defects, and endocrinopathy syndrome 9.7
1189 cholangiocarcinoma 9.7
1190 autoimmune uveitis 9.7
1191 fetal alcohol syndrome 9.7
1192 fetal alcohol spectrum disorder 9.7
1193 paraganglioma 9.7
1194 pervasive developmental disorder 9.7
1195 cholelithiasis 9.7
1196 cystinosis 9.7
1197 microcytic anemia 9.7
1198 filarial elephantiasis 9.7
1199 hereditary spherocytosis 9.7
1200 familial hypercholesterolemia 9.7
1201 oligospermia 9.7
1202 adult-onset still's disease 9.7
1203 fungal infectious disease 9.7
1204 myeloproliferative neoplasm 9.7
1205 neonatal jaundice 9.7
1206 gastric adenocarcinoma 9.7
1207 coronary stenosis 9.7
1208 clear cell renal cell carcinoma 9.7
1209 hypokalemia 9.7
1210 large cell carcinoma 9.7
1211 intrahepatic cholangiocarcinoma 9.7
1212 hepatoblastoma 9.7
1213 bronchiectasis 9.7
1214 pulmonary emphysema 9.7
1215 neonatal abstinence syndrome 9.7
1216 drug dependence 9.7
1217 cytochrome p450 oxidoreductase deficiency 9.7
1218 acute ackee fruit intoxication 9.7
1219 bronchopulmonary dysplasia 9.7
1220 heavy metal poisoning 9.7
1221 nephrogenic systemic fibrosis 9.7
1222 ring chromosome 2 9.7
1223 stenotrophomonas maltophilia infection 9.7
1224 toxic oil syndrome 9.7
1225 cocaine intoxication 9.7
1226 spastic ataxia 1, autosomal dominant 9.7
1227 optic atrophy with demyelinating disease of cns 9.7
1228 neurofibroma 9.7
1229 lymphatic system disease 9.7 MIR96 MIR223 MIR20A MIR17 MIR145 MIR142
1230 male reproductive organ cancer 9.7 MIR96 MIR223 MIR20A MIR17 MIR145 MIR142
1231 male reproductive system disease 9.7 MIR96 MIR223 MIR20A MIR17 MIR145 MIR142
1232 endocrine gland cancer 9.7 MIR96 MIR223 MIR20A MIR17 MIR145 MIR142
1233 floating-harbor syndrome 9.6
1234 gastroesophageal reflux 9.6
1235 alopecia, androgenetic, 1 9.6
1236 angelman syndrome 9.6
1237 hawkinsinuria 9.6
1238 legg-calve-perthes disease 9.6
1239 proline-negative auxotroph of hamster, complementation of 9.6
1240 scoliosis, isolated 1 9.6
1241 acyl-coa dehydrogenase, very long-chain, deficiency of 9.6
1242 alkaptonuria 9.6
1243 leber congenital amaurosis 1 9.6
1244 argininemia 9.6
1245 aspartylglucosaminuria 9.6
1246 citrullinemia, classic 9.6
1247 cystinuria 9.6
1248 fructose intolerance, hereditary 9.6
1249 fructose-1,6-bisphosphatase deficiency 9.6
1250 homocystinuria due to deficiency of n -methylenetetrahydrofolate reductase activity 9.6
1251 carbamoyl phosphate synthetase i deficiency, hyperammonemia due to 9.6
1252 mucopolysaccharidosis, type iiia 9.6
1253 neuraminidase deficiency 9.6
1254 hyper-igd syndrome 9.6
1255 polycythemia vera 9.6
1256 refsum disease, classic 9.6
1257 infantile sialic acid storage disease 9.6
1258 spermatogenic failure 4 9.6
1259 sulfite oxidase deficiency, isolated 9.6
1260 tyrosinemia, type iii 9.6
1261 fragile x syndrome 9.6
1262 agammaglobulinemia, x-linked 9.6
1263 mend syndrome 9.6
1264 ichthyosis, x-linked 9.6
1265 premature ovarian failure 1 9.6
1266 convulsions, familial infantile, with paroxysmal choreoathetosis 9.6
1267 salla disease 9.6
1268 transaldolase deficiency 9.6
1269 scheie syndrome 9.6
1270 epilepsy, partial, with pericentral spikes 9.6
1271 patent ductus arteriosus 1 9.6
1272 legionnaire disease 9.6
1273 aromatic l-amino acid decarboxylase deficiency 9.6
1274 cavitary optic disc anomalies 9.6
1275 neurodegeneration due to cerebral folate transport deficiency 9.6
1276 hypotrichosis and recurrent skin vesicles 9.6
1277 fanconi renotubular syndrome 2 9.6
1278 alpha-1-antitrypsin deficiency 9.6
1279 hypertelorism, preauricular sinus, punctal pits, and deafness 9.6
1280 pulmonary hypertension, primary, 3 9.6
1281 pulmonary hypertension, primary, 4 9.6
1282 bainbridge-ropers syndrome 9.6
1283 chronic ulcer of skin 9.6
1284 angiosarcoma 9.6
1285 superficial mycosis 9.6
1286 otomycosis 9.6
1287 fusariosis 9.6
1288 congenital hypothyroidism 9.6
1289 hypermethioninemia 9.6
1290 extrapulmonary tuberculosis 9.6
1291 early infantile epileptic encephalopathy 9.6
1292 lymphoplasmacytic lymphoma 9.6
1293 peripheral t-cell lymphoma 9.6
1294 limb ischemia 9.6
1295 renal fibrosis 9.6
1296 ovarian clear cell carcinoma 9.6
1297 cardiac arrest 9.6
1298 transient neonatal diabetes mellitus 9.6
1299 3-methylglutaconic aciduria 9.6
1300 glucocorticoid-induced osteoporosis 9.6
1301 waldenstroem's macroglobulinemia 9.6
1302 muscular disease 9.6
1303 childhood acute lymphocytic leukemia 9.6
1304 igg4-related disease 9.6
1305 aortic dissection 9.6
1306 multicentric castleman disease 9.6
1307 castleman disease 9.6
1308 leber plus disease 9.6
1309 pelvic inflammatory disease 9.6
1310 corneal disease 9.6
1311 keratoconus 9.6
1312 left bundle branch hemiblock 9.6
1313 microinvasive gastric cancer 9.6
1314 osteomalacia 9.6
1315 fanconi syndrome 9.6
1316 hand, foot and mouth disease 9.6
1317 vitamin k deficiency bleeding 9.6
1318 hemopericardium 9.6
1319 onchocerciasis 9.6
1320 neonatal diabetes mellitus 9.6
1321 pericardial effusion 9.6
1322 conn's syndrome 9.6
1323 otosclerosis 9.6
1324 mucopolysaccharidosis iii 9.6
1325 plasmodium vivax malaria 9.6
1326 tick-borne relapsing fever 9.6
1327 campylobacteriosis 9.6
1328 hypoactive sexual desire disorder 9.6
1329 pleuropneumonia 9.6
1330 hereditary angioedema 9.6
1331 aggressive periodontitis 9.6
1332 dermatomycosis 9.6
1333 keratosis 9.6
1334 neuroendocrine tumor 9.6
1335 peritoneal mesothelioma 9.6
1336 trichomoniasis 9.6
1337 coccidiosis 9.6
1338 leptospirosis 9.6
1339 liver angiosarcoma 9.6
1340 laryngeal squamous cell carcinoma 9.6
1341 cervix carcinoma 9.6
1342 carbohydrate metabolic disorder 9.6
1343 breast ductal carcinoma 9.6
1344 gm2 gangliosidosis 9.6
1345 glycoproteinosis 9.6
1346 systemic mastocytosis 9.6
1347 mastocytosis 9.6
1348 pulmonary fibrosis 9.6
1349 lung squamous cell carcinoma 9.6
1350 adrenal carcinoma 9.6
1351 ebola hemorrhagic fever 9.6
1352 ureteral obstruction 9.6
1353 overnutrition 9.6
1354 malignant pleural mesothelioma 9.6
1355 intestinal obstruction 9.6
1356 myeloid sarcoma 9.6
1357 seborrheic dermatitis 9.6
1358 actinic keratosis 9.6
1359 atrophic gastritis 9.6
1360 status asthmaticus 9.6
1361 tracheitis 9.6
1362 babesiosis 9.6
1363 bacterial conjunctivitis 9.6
1364 trichinosis 9.6
1365 cocaine dependence 9.6
1366 hyperphenylalaninemia 9.6
1367 classic galactosemia and clinical variant galactosemia 9.6
1368 dystrophinopathies 9.6
1369 al amyloidosis 9.6
1370 bowen's disease 9.6
1371 complete androgen insensitivity syndrome 9.6
1372 dihydroxyadeninuria 9.6
1373 dwarfism 9.6
1374 mycobacterium fortuitum 9.6
1375 mycobacterium gordonae 9.6
1376 neonatal meningitis 9.6
1377 ocular toxoplasmosis 9.6
1378 ornithinemia 9.6
1379 refsum disease, infantile form 9.6
1380 sutton disease 2 9.6
1381 thiopurine s methyltranferase deficiency 9.6
1382 aldosterone-producing adenoma 9.6
1383 familial hyperaldosteronism 9.6
1384 idiopathic infantile hypercalcemia 9.6
1385 immune hydrops fetalis 9.6
1386 acute radiation syndrome 9.6
1387 folinic acid-responsive seizures 9.6
1388 primary progressive freezing gait 9.6
1389 lysosomal disease 9.6
1390 neurofibromatosis, type ii 9.6
1391 coproporphyria, hereditary 9.6
1392 craniometaphyseal dysplasia, autosomal dominant 9.6
1393 optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy 9.6
1394 diabetes mellitus, noninsulin-dependent 9.6
1395 discrimination, two-point, reduction in 9.6
1396 duane retraction syndrome 1 9.6
1397 dementia, lewy body 9.6
1398 multiple endocrine neoplasia, type i 9.6
1399 erythroleukemia, familial 9.6
1400 exostoses, multiple, type i 9.6
1401 fibrosis of extraocular muscles, congenital, 1 9.6
1402 immunoglobulin a deficiency 1 9.6
1403 gerstmann-straussler disease 9.6
1404 gilles de la tourette syndrome 9.6
1405 clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly 9.6
1406 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.6
1407 cardiomyopathy, familial hypertrophic, 2 9.6
1408 bladder diverticulum 9.6
1409 leukemia, chronic lymphocytic 2 9.6
1410 episodic ataxia, type 2 9.6
1411 apnea, obstructive sleep 9.6
1412 annular erythema 9.6
1413 anisocoria 9.6
1414 aniridia 1 9.6
1415 periodic fever, familial, autosomal dominant 9.6
1416 hypercalciuria, absorptive, 2 9.6
1417 endosteal hyperostosis, autosomal dominant 9.6
1418 ichthyosis hystrix, curth-macklin type 9.6
1419 intussusception 9.6
1420 keratitis, hereditary 9.6
1421 kleine-levin hibernation syndrome 9.6
1422 leiomyoma, uterine 9.6
1423 leukemia, acute monocytic 9.6
1424 lichen sclerosus et atrophicus 9.6
1425 marfan syndrome 9.6
1426 thyroid carcinoma, familial medullary 9.6
1427 medulloblastoma 9.6
1428 melkersson-rosenthal syndrome 9.6
1429 meniere disease 9.6
1430 antigen defined by monoclonal antibody aj9 9.6
1431 facioscapulohumeral muscular dystrophy 1 9.6
1432 neutrophil migration 9.6
1433 multicentric carpotarsal osteolysis syndrome 9.6
1434 otitis media 9.6
1435 paramyotonia congenita of von eulenburg 9.6
1436 benign chronic pemphigus 9.6
1437 pemphigus vulgaris, familial 9.6
1438 pneumothorax, primary spontaneous 9.6
1439 peutz-jeghers syndrome 9.6
1440 porphyria cutanea tarda, type i 9.6
1441 porphyria cutanea tarda 9.6
1442 rubinstein-taybi syndrome 1 9.6
1443 small cell cancer of the lung 9.6
1444 spinocerebellar ataxia 2 9.6
1445 temporal arteritis 9.6
1446 tetralogy of fallot 9.6
1447 digeorge syndrome 9.6
1448 down syndrome 9.6
1449 tuberous sclerosis 1 9.6
1450 muckle-wells syndrome 9.6
1451 varicose veins 9.6
1452 vasculopathy, retinal, with cerebral leukodystrophy 9.6
1453 von hippel-lindau syndrome 9.6
1454 williams-beuren syndrome 9.6
1455 chiari malformation type ii 9.6
1456 premature centromere division 9.6
1457 cryptorchidism, unilateral or bilateral 9.6
1458 cystic fibrosis 9.6
1459 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 9.6
1460 disseminated sclerosis with narcolepsy 9.6
1461 enterocolitis 9.6
1462 gaucher disease, type i 9.6
1463 glycogen storage disease ii 9.6
1464 goodpasture syndrome 9.6
1465 hydrocephalus, congenital, 1 9.6
1466 hydrocephalus due to congenital stenosis of aqueduct of sylvius 9.6
1467 hypoadrenocorticism, familial 9.6
1468 hypogonadism, male 9.6
1469 lambert syndrome 9.6
1470 leprosy 3 9.6
1471 multiple pterygium syndrome, lethal type 9.6
1472 epilepsy, myoclonic juvenile 9.6
1473 myxedema 9.6
1474 niemann-pick disease, type c1 9.6
1475 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 1 9.6
1476 nonarteritic anterior ischemic optic neuropathy 9.6
1477 papilloma of choroid plexus 9.6
1478 periodontitis, chronic 9.6
1479 intrinsic factor deficiency 9.6
1480 pierre robin syndrome 9.6
1481 inflammatory bowel disease 1 9.6
1482 hemophagocytic lymphohistiocytosis, familial, 1 9.6
1483 retinitis pigmentosa 9.6
1484 spastic paraplegia 15, autosomal recessive 9.6
1485 spastic pseudosclerosis 9.6
1486 asplenia, isolated congenital 9.6
1487 tardive dyskinesia 9.6
1488 wernicke-korsakoff syndrome 9.6
1489 wiskott-aldrich syndrome 9.6
1490 arts syndrome 9.6
1491 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 9.6
1492 muscular dystrophy, duchenne type 9.6
1493 otopalatodigital syndrome, type i 9.6
1494 paine syndrome 9.6
1495 androgen insensitivity, partial 9.6
1496 reticuloendotheliosis, x-linked 9.6
1497 rett syndrome 9.6
1498 parkinson disease 2, autosomal recessive juvenile 9.6
1499 spinocerebellar ataxia 4 9.6
1500 pituitary adenoma, prolactin-secreting 9.6
1501 budd-chiari syndrome 9.6
1502 charcot-marie-tooth disease, demyelinating, type 1c 9.6
1503 supranuclear palsy, progressive, 1 9.6
1504 microphthalmia, syndromic 8 9.6
1505 systemic lupus erythematosus 1 9.6
1506 alzheimer disease 5 9.6
1507 cholestasis, progressive familial intrahepatic, 3 9.6
1508 macular degeneration, age-related, 1 9.6
1509 dermatitis, atopic 9.6
1510 polydactyly 9.6
1511 sickle cell anemia 9.6
1512 cervical cancer 9.6
1513 megalencephalic leukoencephalopathy with subcortical cysts 1 9.6
1514 chudley-mccullough syndrome 9.6
1515 mitochondrial complex v deficiency, nuclear type 1 9.6
1516 inflammatory bowel disease 3 9.6
1517 huntington disease-like 3 9.6
1518 psoriasis 6 9.6
1519 paragangliomas 3 9.6
1520 schizophrenia 10 9.6
1521 inflammatory bowel disease 5 9.6
1522 huntington disease-like 2 9.6
1523 longevity 2 9.6
1524 amyotrophic lateral sclerosis 3 9.6
1525 lymphangioleiomyomatosis 9.6
1526 gastrointestinal stromal tumor 9.6
1527 creatinine clearance quantitative trait locus 9.6
1528 endometrial cancer 9.6
1529 respiratory rhythmicity in sleep 9.6
1530 aplastic anemia 9.6
1531 alzheimer disease 10 9.6
1532 chromosome 16p13.3 deletion syndrome, proximal 9.6
1533 leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation 9.6
1534 charcot-marie-tooth disease, type 4j 9.6
1535 legius syndrome 9.6
1536 primary lateral sclerosis, adult, 1 9.6
1537 spastic paraplegia 39, autosomal recessive 9.6
1538 diabetes mellitus, ketosis-prone 9.6
1539 microvascular complications of diabetes 3 9.6
1540 microvascular complications of diabetes 4 9.6
1541 microvascular complications of diabetes 6 9.6
1542 microvascular complications of diabetes 7 9.6
1543 synesthesia 9.6
1544 hearing loss, noise-induced 9.6
1545 bile acid malabsorption, primary 9.6
1546 ectodermal dysplasia-syndactyly syndrome 1 9.6
1547 ectodermal dysplasia-syndactyly syndrome 2 9.6
1548 complement component 3 deficiency, autosomal recessive 9.6
1549 hirschsprung disease, cardiac defects, and autonomic dysfunction 9.6
1550 beta-thalassemia 9.6
1551 delayed sleep phase disorder 9.6
1552 glutathione peroxidase deficiency 9.6
1553 barrett esophagus 9.6
1554 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.6
1555 palmoplantar carcinoma, multiple self-healing 9.6
1556 epileptic encephalopathy, childhood-onset 9.6
1557 arthrogryposis, mental retardation, and seizures 9.6
1558 hydrops, lactic acidosis, and sideroblastic anemia 9.6
1559 retinal dystrophy with or without macular staphyloma 9.6
1560 helix syndrome 9.6
1561 alkuraya-kucinskas syndrome 9.6
1562 fetal akinesia deformation sequence 2 9.6
1563 nephrotic syndrome, type 21 9.6
1564 lipoprotein quantitative trait locus 9.6
1565 autoimmune peripheral neuropathy 9.6
1566 erythema multiforme 9.6
1567 epstein-barr virus hepatitis 9.6
1568 lambert-eaton myasthenic syndrome 9.6
1569 hypophosphatemia 9.6
1570 brugada syndrome 9.6
1571 hyperphosphatemia 9.6
1572 multinodular goiter 9.6
1573 exanthema subitum 9.6
1574 variola major 9.6
1575 paralytic poliomyelitis 9.6
1576 congenital generalized lipodystrophy 9.6
1577 distal arthrogryposis 9.6
1578 spastic cerebral palsy 9.6
1579 chorioamnionitis 9.6
1580 3-methylcrotonyl-coa carboxylase deficiency 9.6
1581 congenital intrinsic factor deficiency 9.6
1582 third-degree atrioventricular block 9.6
1583 peripheral artery disease 9.6
1584 segmental dystonia 9.6
1585 anismus 9.6
1586 oculogyric crisis 9.6
1587 follicular lymphoma 9.6
1588 adrenal cortical adenoma 9.6
1589 hereditary ataxia 9.6
1590 paraphilia disorder 9.6
1591 apperceptive agnosia 9.6
1592 finger agnosia 9.6
1593 form agnosia 9.6
1594 ischemic colitis 9.6
1595 basal ganglia calcification 9.6
1596 stuttering 9.6
1597 paroxysmal nocturnal hemoglobinuria 9.6
1598 inguinal hernia 9.6
1599 breast abscess 9.6
1600 myelomeningocele 9.6
1601 zika fever 9.6
1602 pollen allergy 9.6
1603 autosomal recessive congenital ichthyosis 9.6
1604 hyperekplexia 9.6
1605 early-onset parkinson's disease 9.6
1606 progressive familial intrahepatic cholestasis 9.6
1607 intrahepatic cholestasis of pregnancy 9.6
1608 myoglobinuria 9.6
1609 hepatic veno-occlusive disease 9.6
1610 mucositis 9.6
1611 polycystic kidney disease 9.6
1612 desmoid tumor 9.6
1613 cortisone reductase deficiency 9.6
1614 tabes dorsalis 9.6
1615 cycloplegia 9.6
1616 cerebral artery occlusion 9.6
1617 sialadenitis 9.6
1618 chronic meningitis 9.6
1619 hypopyon 9.6
1620 glucose intolerance 9.6
1621 tropical sprue 9.6
1622 renal hypertension 9.6
1623 portal hypertension 9.6
1624 gastric ulcer 9.6
1625 malignant hypertension 9.6
1626 murray valley encephalitis 9.6
1627 partial third-nerve palsy 9.6
1628 microcephaly 9.6
1629 intracranial aneurysm 9.6
1630 spastic diplegia 9.6
1631 spastic quadriplegia 9.6
1632 asphyxia neonatorum 9.6
1633 prostatic hypertrophy 9.6
1634 anhidrosis 9.6
1635 disseminated intravascular coagulation 9.6
1636 keratomalacia 9.6
1637 megacolon 9.6
1638 alternating exotropia 9.6
1639 exotropia 9.6
1640 autonomic neuropathy 9.6
1641 oculomotor nerve paralysis 9.6
1642 cauda equina syndrome 9.6
1643 hyperandrogenism 9.6
1644 presbyopia 9.6
1645 clubfoot 9.6
1646 mononeuropathy 9.6
1647 ischemic neuropathy 9.6
1648 esophagitis 9.6
1649 hypertrophic cardiomyopathy 9.6
1650 radial neuropathy 9.6
1651 common variable immunodeficiency 9.6
1652 dengue disease 9.6
1653 plica syndrome 9.6
1654 male infertility 9.6
1655 fetishism 9.6
1656 spinal muscular atrophy 9.6
1657 complex partial epilepsy 9.6
1658 pathological gambling 9.6
1659 secondary hyperparathyroidism 9.6
1660 dyscalculia 9.6
1661 paracoccidioidomycosis 9.6
1662 hypochondriasis 9.6
1663 vertebrobasilar insufficiency 9.6
1664 relapsing fever 9.6
1665 branch retinal artery occlusion 9.6
1666 vertebral artery insufficiency 9.6
1667 central retinal artery occlusion 9.6
1668 severe pre-eclampsia 9.6
1669 klebsiella pneumonia 9.6
1670 pedophilia 9.6
1671 megaloblastic anemia 9.6
1672 skin sarcoidosis 9.6
1673 hepatic encephalopathy 9.6
1674 scleritis 9.6
1675 osteopetrosis 9.6
1676 optic disk drusen 9.6
1677 cholestasis 9.6
1678 beriberi 9.6
1679 achromatopsia 9.6
1680 somatization disorder 9.6
1681 bladder neck obstruction 9.6
1682 rubeosis iridis 9.6
1683 poems syndrome 9.6
1684 autoimmune polyendocrine syndrome 9.6
1685 alcoholic neuropathy 9.6
1686 oral candidiasis 9.6
1687 mixed malaria 9.6
1688 capillary leak syndrome 9.6
1689 sporotrichosis 9.6
1690 niemann-pick disease 9.6
1691 foster-kennedy syndrome 9.6
1692 papilledema 9.6
1693 labyrinthitis 9.6
1694 centronuclear myopathy 9.6
1695 olivopontocerebellar atrophy 9.6
1696 gingival disease 9.6
1697 cholera 9.6
1698 arthus reaction 9.6
1699 angioedema 9.6
1700 lymphadenitis 9.6
1701 hypoglycemic coma 9.6
1702 ventricular septal defect 9.6
1703 chronic cystitis 9.6
1704 neovascular glaucoma 9.6
1705 ichthyosis 9.6
1706 duodenal ulcer 9.6
1707 histoplasmosis 9.6
1708 cryptosporidiosis 9.6
1709 squamous cell carcinoma 9.6
1710 factitious disorder 9.6
1711 thyroid gland cancer 9.6
1712 neuroendocrine carcinoma 9.6
1713 calcinosis 9.6
1714 atrial heart septal defect 9.6
1715 gaucher's disease 9.6
1716 hypothalamic disease 9.6
1717 cholecystitis 9.6
1718 exostosis 9.6
1719 encephalomalacia 9.6
1720 hyperostosis 9.6
1721 brain germinoma 9.6
1722 brain sarcoma 9.6
1723 vaginitis 9.6
1724 essential thrombocythemia 9.6
1725 thrombocytosis 9.6
1726 basilar artery insufficiency 9.6
1727 pharyngitis 9.6
1728 keratopathy 9.6
1729 nocardiosis 9.6
1730 monoclonal paraproteinemia 9.6
1731 macrocytic anemia 9.6
1732 gangliocytoma 9.6
1733 glomus tumor 9.6
1734 acromegaly 9.6
1735 chronic inflammatory demyelinating polyneuritis 9.6
1736 kidney cancer 9.6
1737 synovitis 9.6
1738 sick building syndrome 9.6
1739 contact dermatitis 9.6
1740 glucosephosphate dehydrogenase deficiency 9.6
1741 cryoglobulinemia 9.6
1742 germ cell cancer 9.6
1743 early myoclonic encephalopathy 9.6
1744 cystic lymphangioma 9.6
1745 gingival overgrowth 9.6
1746 multiple endocrine neoplasia 9.6
1747 teratoma 9.6
1748 angiomyolipoma 9.6
1749 gm1 gangliosidosis 9.6
1750 histrionic personality disorder 9.6
1751 fibrosarcoma 9.6
1752 liposarcoma 9.6
1753 cerebritis 9.6
1754 plague 9.6
1755 cellulitis 9.6
1756 mixed connective tissue disease 9.6
1757 chronic wasting disease 9.6
1758 superior mesenteric artery syndrome 9.6
1759 acute retinal necrosis syndrome 9.6
1760 intermittent claudication 9.6
1761 plasmacytoma 9.6
1762 placental insufficiency 9.6
1763 thyroid gland medullary carcinoma 9.6
1764 eosinophilic gastroenteritis 9.6
1765 heart valve disease 9.6
1766 blood group incompatibility 9.6
1767 echolalia 9.6
1768 intracranial thrombosis 9.6
1769 hyperglycemia 9.6
1770 hypertrichosis 9.6
1771 brain stem glioma 9.6
1772 akinetic mutism 9.6
1773 erdheim-chester disease 9.6
1774 non-langerhans-cell histiocytosis 9.6
1775 intracranial embolism 9.6
1776 hepatitis e 9.6
1777 central nervous system germinoma 9.6
1778 seminoma 9.6
1779 multiple chemical sensitivity 9.6
1780 uremia 9.6
1781 intracranial hypotension 9.6
1782 somatoform disorder 9.6
1783 immune-complex glomerulonephritis 9.6
1784 ganglioneuroma 9.6
1785 sebaceous adenocarcinoma 9.6
1786 rhabdoid meningioma 9.6
1787 mixed glioma 9.6
1788 ganglioglioma 9.6
1789 urinary tract obstruction 9.6
1790 chronic polyneuropathy 9.6
1791 von economo's disease 9.6
1792 hemangioblastoma 9.6
1793 anterograde amnesia 9.6
1794 third cranial nerve disease 9.6
1795 retinal disease 9.6
1796 hemoglobinuria 9.6
1797 inferior myocardial infarction 9.6
1798 eosinophilic pneumonia 9.6
1799 microglandular adenosis 9.6
1800 gliomatosis cerebri 9.6
1801 mitochondrial myopathy 9.6
1802 protoplasmic astrocytoma 9.6
1803 meningothelial meningioma 9.6
1804 childhood leukemia 9.6
1805 carotid artery occlusion 9.6
1806 osteochondrosis 9.6
1807 septic arthritis 9.6
1808 scabies 9.6
1809 complement component 3 deficiency 9.6
1810 kidney angiomyolipoma 9.6
1811 localized scleroderma 9.6
1812 retinal artery occlusion 9.6
1813 subcorneal pustular dermatosis 9.6
1814 monocytic leukemia 9.6
1815 scarlet fever 9.6
1816 eating disorder 9.6
1817 perinatal necrotizing enterocolitis 9.6
1818 molluscum contagiosum 9.6
1819 skin melanoma 9.6
1820 autosomal dominant polycystic kidney disease 9.6
1821 macroglobulinemia 9.6
1822 peliosis hepatis 9.6
1823 visceral leishmaniasis 9.6
1824 lichen planus 9.6
1825 urea cycle disorder 9.6
1826 cleft lip 9.6
1827 urethral diverticulum 9.6
1828 hypopituitarism 9.6
1829 acute myocardial infarction 9.6
1830 allergic asthma 9.6
1831 postpartum depression 9.6
1832 necrotizing fasciitis 9.6
1833 episodic ataxia 9.6
1834 congenital nystagmus 9.6
1835 aphthous stomatitis 9.6
1836 myocardial stunning 9.6
1837 hypotropia 9.6
1838 hypervitaminosis d 9.6
1839 limb-girdle muscular dystrophy 9.6
1840 csf1r-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia 9.6
1841 syne1 deficiency 9.6
1842 sickle cell disease 9.6
1843 acute graft versus host disease 9.6
1844 acute monoblastic leukemia 9.6
1845 acute mountain sickness 9.6
1846 acute posterior multifocal placoid pigment epitheliopathy 9.6
1847 acute zonal occult outer retinopathy 9.6
1848 adenosylcobalamin deficiency 9.6
1849 alopecia totalis 9.6
1850 aminoaciduria 9.6
1851 anaplastic oligoastrocytoma 9.6
1852 anaplastic oligodendroglioma 9.6
1853 antisynthetase syndrome 9.6
1854 athetosis 9.6
1855 candida glabrata 9.6
1856 carcinoid syndrome 9.6
1857 chromosomal triplication 9.6
1858 cluttering 9.6
1859 congenital extrahepatic portosystemic shunt 9.6
1860 congenital hydrocephalus 9.6
1861 cytomegalic inclusion disease 9.6
1862 diencephalic syndrome 9.6
1863 drug reaction with eosinophilia and systemic symptoms 9.6
1864 fasting hypoglycemia 9.6
1865 foix chavany marie syndrome 9.6
1866 gangliosidosis 9.6
1867 growth hormone deficiency 9.6
1868 hansen's disease 9.6
1869 hashimoto encephalopathy 9.6
1870 hemorrhagic proctocolitis 9.6
1871 heparin-induced thrombocytopenia 9.6
1872 herpes zoster ophthalmicus 9.6
1873 hip subluxation 9.6
1874 homologous wasting disease 9.6
1875 hypertrophic olivary degeneration 9.6
1876 hypocomplementemic urticarial vasculitis 9.6
1877 idiopathic edema 9.6
1878 idiopathic neutropenia 9.6
1879 idiopathic spinal cord herniation 9.6
1880 leukoplakia 9.6
1881 lymphocytic hypophysitis 9.6
1882 lymphoma aids related 9.6
1883 lymphomatous thyroiditis 9.6
1884 lymphosarcoma 9.6
1885 macrophage activation syndrome 9.6
1886 mycobacterium kansasii 9.6
1887 necrotizing autoimmune myopathy 9.6
1888 nodular regenerative hyperplasia 9.6
1889 nondystrophic myotonia 9.6
1890 oral leukoplakia 9.6
1891 pediatric acute-onset neuropsychiatric syndrome 9.6
1892 pituitary stalk interruption syndrome 9.6
1893 pontine hemorrhage 9.6
1894 precocious puberty 9.6
1895 progressive encephalomyelitis with rigidity and myoclonus 9.6
1896 pulmonary hyalinizing granuloma 9.6
1897 pyogenic granuloma 9.6
1898 recurrent peripheral facial palsy 9.6
1899 rheumatoid factor-negative juvenile idiopathic arthritis 9.6
1900 scleromyxedema 9.6
1901 spastic paraplegia 10 9.6
1902 spastic paraplegia 15 9.6
1903 spastic paraplegia 39 9.6
1904 spinal shock 9.6
1905 splenomegaly 9.6
1906 streptococcal group a invasive disease 9.6
1907 thunderclap headache 9.6
1908 wells syndrome 9.6
1909 age-related hearing loss 9.6
1910 central precocious puberty 9.6
1911 isolated pierre robin sequence 9.6
1912 angiomatosis 9.6
1913 cavernous malformation 9.6
1914 cerebral beriberi 9.6
1915 cerebral hypoxia 9.6
1916 extrapontine myelinolysis 9.6
1917 hydromyelia 9.6
1918 paroxysmal choreoathetosis 9.6
1919 persistent vegetative state 9.6
1920 pituitary tumors 9.6
1921 postherpetic neuralgia 9.6
1922 spinal cord infarction 9.6
1923 thomsen's myotonia 9.6
1924 b-cell non-hodgkin lymphoma 9.6
1925 cleft lip/palate 9.6
1926 trigeminal autonomic cephalalgia 9.6
1927 high-grade astrocytoma 9.6
1928 autosomal recessive spastic ataxia 9.6
1929 lmna-related cardiocutaneous progeria syndrome 9.6
1930 familial intrahepatic cholestasis 9.6
1931 disorder of copper metabolism 9.6
1932 rare paroxysmal movement disorder 9.6
1933 aggressive b-cell non-hodgkin lymphoma 9.6
1934 spontaneous intracranial hypotension 9.6
1935 mitochondrial neurogastrointestinal encephalomyopathy 9.6
1936 secondary vasculitis 9.6
1937 erythema multiforme major 9.6
1938 methanol poisoning 9.6
1939 congenital amyoplasia 9.6
1940 igg4-related thyroid disease 9.6
1941 pneumococcal meningitis 9.6
1942 bickerstaff brainstem encephalitis 9.6
1943 focal myositis 9.6
1944 serotonin syndrome 9.6
1945 diffuse alveolar hemorrhage 9.6
1946 radiation myelitis 9.6
1947 secondary erythromelalgia 9.6
1948 premature aging 9.6
1949 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.6
1950 large granular lymphocyte leukemia 9.6
1951 rare tumor 9.6
1952 coronary ostial stenosis or atresia 9.6
1953 acute myeloid leukemia with 11q23 abnormalities 9.6
1954 acute motor axonal neuropathy 9.6
1955 accessory mitral valve tissue 9.6
1956 undetermined colitis 9.6
1957 precursor t-cell acute lymphoblastic leukemia 9.6
1958 secondary syringomyelia 9.6
1959 achondroplasia 9.5
1960 alzheimer disease 2 9.5
1961 aortic valve disease 1 9.5
1962 exudative vitreoretinopathy 1 9.5
1963 fucosidase regulator 9.5
1964 glaucoma, primary open angle 9.5
1965 diaphragmatic hernia, congenital 9.5
1966 congenital anomalies of kidney and urinary tract 2 9.5
1967 immunoglobulin e concentration, serum 9.5
1968 cholestasis, intrahepatic, of pregnancy, 1 9.5
1969 lymphatic malformation 5 9.5
1970 melanoma, uveal 9.5
1971 mesothelioma, malignant 9.5
1972 antigen defined by monoclonal antibody t87 9.5
1973 nondisjunction 9.5
1974 hyperuricemic nephropathy, familial juvenile, 1 9.5
1975 amyotrophy, hereditary neuralgic 9.5
1976 pectus excavatum 9.5
1977 polydactyly, preaxial i 9.5
1978 prader-willi syndrome 9.5
1979 pulmonary fibrosis, idiopathic 9.5
1980 cardiomyopathy, familial hypertrophic, 1 9.5
1981 alpha-methylacetoacetic aciduria 9.5
1982 iron-refractory iron deficiency anemia 9.5
1983 cystathioninuria 9.5
1984 d-glyceric aciduria 9.5
1985 schopf-schulz-passarge syndrome 9.5
1986 galactosemia iii 9.5
1987 gapo syndrome 9.5
1988 glycogen storage disease ia 9.5
1989 glycogen storage disease iii 9.5
1990 l-2-hydroxyglutaric aciduria 9.5
1991 3-hydroxy-3-methylglutaryl-coa lyase deficiency 9.5
1992 methane production 9.5
1993 myopathy, myosin storage, autosomal recessive 9.5
1994 polycystic kidney disease 4 with or without polycystic liver disease 9.5
1995 short stature-obesity syndrome 9.5
1996 tay-sachs disease 9.5
1997 alport syndrome 1, x-linked 9.5
1998 short tarsus with absence of lower eyelashes 9.5
1999 adenomyosis 9.5
2000 suppression of tumorigenicity 12 9.5
2001 osteoporosis and oculocutaneous hypopigmentation syndrome 9.5
2002 trimethylaminuria 9.5
2003 medullary cystic kidney disease 2 9.5
2004 progressive familial heart block, type ib 9.5
2005 nephrolithiasis, uric acid 9.5
2006 maturity-onset diabetes of the young 9.5
2007 spermatogenic failure 3 9.5
2008 niemann-pick disease, type b 9.5
2009 myopathy, myosin storage, autosomal dominant 9.5
2010 asthma-related traits 2 9.5
2011 leukoencephalopathy, arthritis, colitis, and hypogammaglobulinema 9.5
2012 salt and pepper developmental regression syndrome 9.5
2013 preterm premature rupture of the membranes 9.5
2014 hamamy syndrome 9.5
2015 kawasaki disease 9.5
2016 congenital disorder of glycosylation, type in 9.5
2017 breast-ovarian cancer, familial 2 9.5
2018 parkinsonism-dystonia, infantile, 1 9.5
2019 beta-ureidopropionase deficiency 9.5
2020 disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency 9.5
2021 cyanosis, transient neonatal 9.5
2022 microcephaly, epilepsy, and diabetes syndrome 9.5
2023 mannose-binding lectin deficiency 9.5
2024 ras-associated autoimmune leukoproliferative disorder 9.5
2025 cerebellar ataxia, neuropathy, and vestibular areflexia syndrome 9.5
2026 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.5
2027 nephrotic syndrome, type 8 9.5
2028 hypobetalipoproteinemia, familial, 1 9.5
2029 chops syndrome 9.5
2030 west syndrome 9.5
2031 kashin-beck disease 9.5
2032 streptococcus pneumonia 9.5
2033 2-hydroxyglutaric aciduria 9.5
2034 alcohol-related birth defect 9.5
2035 small cell carcinoma 9.5
2036 polycystic liver disease 9.5
2037 persistent mullerian duct syndrome 9.5
2038 obstructive nephropathy 9.5
2039 childhood acute myeloid leukemia 9.5
2040 endometrial hyperplasia 9.5
2041 coronavirus infectious disease 9.5
2042 tongue carcinoma 9.5
2043 sitosterolemia 9.5
2044 thymus lymphoma 9.5
2045 amyotrophic neuralgia 9.5
2046 short bowel syndrome 9.5
2047 interstitial nephritis 9.5
2048 giardiasis 9.5
2049 chronic pyelonephritis 9.5
2050 japanese encephalitis 9.5
2051 borderline personality disorder 9.5
2052 obsessive-compulsive personality disorder 9.5
2053 ovarian disease 9.5
2054 myiasis 9.5
2055 spotted fever 9.5
2056 appendix cancer 9.5
2057 cat-scratch disease 9.5
2058 endometriosis of ovary 9.5
2059 hypertensive heart disease 9.5
2060 choledocholithiasis 9.5
2061 hepatorenal syndrome 9.5
2062 pulmonary alveolar proteinosis 9.5
2063 dengue hemorrhagic fever 9.5
2064 tinea pedis 9.5
2065 sulfhemoglobinemia 9.5
2066 nephronophthisis 9.5
2067 paronychia 9.5
2068 hellp syndrome 9.5
2069 right bundle branch block 9.5
2070 mycoplasma pneumoniae pneumonia 9.5
2071 glanders 9.5
2072 sapho syndrome 9.5
2073 interstitial cystitis 9.5
2074 blackwater fever 9.5
2075 boutonneuse fever 9.5
2076 sclerosing keratitis 9.5
2077 gonadal dysgenesis 9.5
2078 glossitis 9.5
2079 prostatitis 9.5
2080 echinococcosis 9.5
2081 leiomyosarcoma 9.5
2082 intestinal perforation 9.5
2083 vulvovaginal candidiasis 9.5
2084 transitional cell carcinoma 9.5
2085 myoma 9.5
2086 glycogen storage disease 9.5
2087 acalculous cholecystitis 9.5
2088 cystic kidney disease 9.5
2089 primary hyperoxaluria 9.5
2090 lobular neoplasia 9.5
2091 allergic contact dermatitis 9.5
2092 papillary adenocarcinoma 9.5
2093 gallbladder cancer 9.5
2094 chronic granulomatous disease 9.5
2095 carotid artery disease 9.5
2096 turner syndrome 9.5
2097 gestational trophoblastic neoplasm 9.5
2098 choriocarcinoma 9.5
2099 lactic acidosis 9.5
2100 vaginal discharge 9.5
2101 lynch syndrome 9.5
2102 bladder urothelial carcinoma 9.5
2103 trophoblastic neoplasm 9.5
2104 tinea capitis 9.5
2105 mucoepidermoid carcinoma 9.5
2106 benign meningioma 9.5
2107 bile duct cancer 9.5
2108 proliferative glomerulonephritis 9.5
2109 mesangial proliferative glomerulonephritis 9.5
2110 adenocarcinoma in situ 9.5
2111 t-cell acute lymphoblastic leukemia 9.5
2112 aortic valve insufficiency 9.5
2113 thyroid hyalinizing trabecular adenoma 9.5
2114 follicular adenoma 9.5
2115 adrenal adenoma 9.5
2116 compartment syndrome 9.5
2117 fascioliasis 9.5
2118 evans' syndrome 9.5
2119 cowpox 9.5
2120 pityriasis versicolor 9.5
2121 lipid storage disease 9.5
2122 dientamoebiasis 9.5
2123 systolic heart failure 9.5
2124 hemorrhoid 9.5
2125 albinism 9.5
2126 hypoalphalipoproteinemia 9.5
2127 morquio syndrome 9.5
2128 primary trimethylaminuria 9.5
2129 aminoacidopathies 9.5
2130 auditory neuropathy spectrum disorder 9.5
2131 biliary tract cancer 9.5
2132 corticobasal degeneration 9.5
2133 distomatosis 9.5
2134 early-onset, autosomal dominant alzheimer disease 9.5
2135 exercise-induced anaphylaxis 9.5
2136 meningococcal infection 9.5
2137 microscopic polyangiitis 9.5
2138 mthfr gene variant 9.5
2139 mycetoma 9.5
2140 mycobacterium chelonae 9.5
2141 mycobacterium xenopi 9.5
2142 neonatal stroke 9.5
2143 oral lichen planus 9.5
2144 ring chromosome 3 9.5
2145 slipped capital femoral epiphysis 9.5
2146 stachybotrys chartarum 9.5
2147 triploidy 9.5
2148 undifferentiated connective tissue disease 9.5
2149 febrile seizures 9.5
2150 glycogen storage disease due to glucose-6-phosphatase deficiency 9.5
2151 uniparental disomy of chromosome 15 9.5
2152 cerebral sinovenous thrombosis 9.5
2153 idiopathic nephrotic syndrome 9.5
2154 ethylene glycol poisoning 9.5
2155 disorder of energy metabolism 9.5
2156 fungal keratitis 9.5
2157 maternal uniparental disomy 9.5
2158 paternal uniparental disomy 9.5
2159 glomerular disease 9.5
2160 uremic pruritus 9.5

Comorbidity relations with Multiple Sclerosis via Phenotypic Disease Network (PDN): (showing 5, show less)


Acute Cystitis Decubitus Ulcer
Neurogenic Bladder Paraplegia
Trigeminal Neuralgia

Graphical network of the top 20 diseases related to Multiple Sclerosis:



Diseases related to Multiple Sclerosis

Symptoms & Phenotypes for Multiple Sclerosis

Human phenotypes related to Multiple Sclerosis:

31 (showing 10, show less)
# Description HPO Frequency HPO Source Accession
1 muscle weakness 31 HP:0001324
2 spasticity 31 HP:0001257
3 depressivity 31 HP:0000716
4 paresthesia 31 HP:0003401
5 emotional lability 31 HP:0000712
6 diplopia 31 HP:0000651
7 urinary incontinence 31 HP:0000020
8 urinary hesitancy 31 HP:0000019
9 incoordination 31 HP:0002311
10 cns demyelination 31 HP:0007305

Symptoms via clinical synopsis from OMIM:

56
Neurologic Central Nervous System:
spasticity
emotional lability
depression
high intensity area in white matter on head mri
cognitive dysfunction
more
Genitourinary Bladder:
urinary incontinence
urinary hesitancy
incomplete bladder emptying

Laboratory Abnormalities:
increased csf immunoglobulin levels
oligoclonal bands in csf
myelin basic protein in csf

Head And Neck Eyes:
diplopia
vision loss, monocular

Neurologic Peripheral Nervous System:
incoordination
weakness